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ABSTRACT 
Polymorphonuclear neutrophils (PMNs) are the first line of defense against 
infectious disease and play a critical role in inflammation. Central to these roles of 
neutrophils are their cytoplasmic granules; some of them are sluggishly mobilized upon 
cell activation, azurophil (primary) granules, and others are readily exocytosed 
following cell activation, specific (secondary) granules, gelatinase-containing tertiary 
granules, and secretory vesicles (phosphasomes). These latter are endocytic in nature. 
Azurophilic granules contain a large number of lytic enzymes that can be detrimental to 
the surrounding tissue if secreted in a deregulated way. Specific and tertiary granules 
constitute a reservoir of plasma membrane proteins that become incorporated into the 
cell surface upon neutrophil activation, and contain a wide array of proteins involved in 
human neutrophil adhesion and extravasation. Thus, secretion of neutrophil granules 
must be tightly controlled to prevent deregulated release of harmful constituents or 
unwanted inflammatory processes. The molecular basis for neutrophil exocytosis is 
being elucidated only in the last few years. A number of SNARE proteins have been 
already identified in human neutrophils, and SNAP-23, VAMP-2 and syntaxins 4 and 6 
have been recently involved in the exocytosis of distinct neutrophil granule subsets. 
Additional proteins, including synaptotagmins, annexins and small G proteins, have 
been also suggested as putative regulators of both Ca2+- and GTP-mediated secretion of 
neutrophil granules. Identification of the essential molecules regulating neutrophil 
granule secretion can provide novel therapeutic targets in the treatment of inflammation. 
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RESUMEN 
Los leucocitos polimorfonucleares neutrófilos (PMNs) constituyen la primera 
línea de defensa frente a la infección y juegan un papel fundamental en los procesos 
inflamatorios. Estas acciones de los neutrófilos se deben en gran medida a sus gránulos 
citoplásmicos, algunos de los cuales se movilizan con dificultad tras la activación 
celular, los gránulos azurófilos (primarios), mientras que otros sufren fácilmente 
exocytosis tras la activación celular, los gránulos específicos (secundarios), los gránulos 
terciarios ricos en gelatinasa y las vesículas secretoras (fosfasomas). Estos últimos son 
de naturaleza endocítica. Los gránulos azurófilos contienen una gran cantidad de 
enzimas líticas que pueden ser perjudiciales para el tejido adyacente si se secretaran de 
una forma desregulada. Los gránulos específicos y terciarios constituyen un reservorio 
de proteínas de la membrana plasmática que se incorporan a la superficie celular tras la 
activación del neutrófilo, y contienen un gran número de proteínas implicadas en la 
adhesión y extravasación de los neutrófilos humanos. De esta forma, la secreción de los 
gránulos del neutrófilo debe estar fuertemente controlada para prevenir la liberación 
desregulada de constituyentes dañinos o procesos inflamatorios no deseados. Las bases 
moleculares de la secreción en el neutrófilo están siendo desveladas solo en los últimos 
años. Se han identificado un cierto número de proteínas SNARE en neutrófilos 
humanos, y SNAP-23, VAMP-2, y sintaxinas 4 y 6 han sido recientemente implicadas 
en la exocytosis de las distintas poblaciones de gránulos. Además, se ha sugerido la 
participación de proteínas adicionales en el control de secreción de los gránulos del 
neutrófilo mediada por Ca2+ y GTP, incluyendo sinaptotagminas, anexinas y proteínas 
G de bajo peso molecular. La identificación de las moléculas esenciales para la 
secreción de los gránulos del neutrófilo puede conducir a nuevas dianas terapéuticas en 
el tratamiento de la inflamación. 
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INTRODUCTION 
Neutrophilic polymorphonuclear leukocytes or polymorphonuclear neutrophils 
(PMNs, neutrophils) play crucial roles in host defense, by phagocytosing and killing 
invading microorganisms, and in the pathogenesis of inflammatory diseases 1,2. The 
neutrophil is the most numerous leukocyte in the adult peripheral blood, 54-62% in the 
leukocyte differential count (3000-6000 cells/µl). At birth, neutrophil concentration is 
about 60%; this level drops to 30% by 4 to 6 months of age. After 4 years the 
concentration of neutrophils gradually increases, until adult values are reached at 6 
years of age. The term granulocyte is often loosely used to refer to neutrophils but 
strictly speaking encompasses the eosinophil (1-3% in the leukocyte differential count, 
50-250 cells/µl) and basophil (0-0.75% in the leukocyte differential count, 15-50 
cells/µl) series as well, even though neutrophils represent more than 96% of all 
granulocytes. Neutrophil is considered both a professional phagocyte as well as an 
inflammatory cell, through exerting two major processes, namely phagocytosis and 
secretion of intracellular granules or vesicles. A common histologic feature of most 
acute immunologically induced tissue injury is the accumulation of neutrophils. The 
acute inflammatory response is characterized by increased neutrophil adherence to 
endothelium, and the accumulation of neutrophils at the site of inflammation can 
promote vascular injury through the secretion of granule constituents, reactive oxygen 
metabolites and phospholipase products, resulting in local edema, thrombosis or 
hemorrhage. Neutrophil, like other inflammatory cells, secrete proteins from 
intracellular vesicles or granules by a process referred to either as exocytosis or as 
degranulation, which is of particular significance with respect to tissue damage in 
inflammatory diseases. Central to the role of neutrophils in inflammation and host 
defense are the constituents of their cytoplasmic granules, which are involved in a wide 
spectrum of functions including engulfment and killing of foreign particles and 
pathogens, cell-cell interaction and adhesion, cell signalling, modulation of the 
surrounding environment, and extravasation. Due to the high amount of dangerous and 
deleterious constituents stored inside the neutrophil cytoplasmic granules, their release 
must be perfectly controlled in order to avoid tissue injury. Exocytosis involves the 
fusion of granules with the plasma membrane, leading to release of granule contents and 
the exposure of granule membrane proteins at the cell surface. Although the secretory 
properties of human neutrophils have long been recognized, the molecular basis for 
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neutrophil exocytosis is now being unravelled. Our recent findings on the functional 
role of SNARE proteins in regulating neutrophil exocytosis 3,4 provide a starting point 
in this isuue. In this review, we discuss the distinct human neutrophil granule 
populations and the molecules currently implicated in their exocytosis. Here I propose a 
tentative molecular model that entails SNARE proteins as major regulators of 
exocytosis of neutrophil cytoplasmic granules. Elucidation of the molecular 
mechanisms involved in granule secretion is not only of interest in neutrophil biology, 
but is also of major pharmacological interest inasmuch as proteins mediating neutrophil 
exocytosis may serve as appropriate targets for anti-inflammatory agents. 
 
NEUTROPHIL MATURATION 
The mature blood neutrophil is a highly specialized, nondividing “end” cell with 
a short life-span. Human mature neutrophils are unable of cell division, and their 
sustained generation by the bone marrow at impressive numbers (0.85-1.6 x 109 
cells/kilogram/day), is the result of a highly controlled, yet incompletely understood, 
process of myelopoiesis. Bone marrow is widely distributed within the various bones, 
weighs about 2600 g (~4.5% of body weight of a normal adult), and ~60% of bone 
marrow nucleated cells are developing neutrophils in different stages of maturation. 
Neutrophils spend most of their lives in the bone marrow (~14 days), where they 
develop (Fig. 1) and are stored before release into the blood, where they circulate for 
about 6-10 h. Then, neutrophils enter the tissues and probably function and live for 1 or 
2 days. Once neutrophils have entered the tissues, they do not return to the blood; the 
flow of cells is unidirectional. During maturation PMNs acquire their granule 
constituents, which equip the activated neutrophils to kill microorganisms and to exert 
their crucial functions in both host defense and inflammation. Unlike mature PMNs, 
neutrophil precursors contain many mitochondria and appear to use respiration to drive 
the required protein synthesis. As maturation proceeds, cells gradually shift to 
glycolysis as their primary energy source, in preparation for the neutrophil’s later duties 
in hypoxic tissues. However, mitochondria are still present in mature neutrophils where 
they may play an important role in regulating their characteristic spontaneous apoptosis 
5. Neutrophil precursors acquire mobility, plasticity, and the abilities to generate oxygen 
reactive species, to secrete granule constituents and to ingest particles, crucial for the 
bactericidal and inflammatory roles of neutrophils. PMN development in the bone 
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marrow has been divided into six stages on the basis of cell size, nuclear morphology 
and granule content 6,7 (Fig. 1). 
 
Myeloblast 
The myeloblast is the earliest recognizable neutrophil precursor, a relatively 
small (~10 µm) undifferentiated cell that is characterized by a large nucleus, showing a 
high nuclear to cytoplasmic ratio, and dispersed nuclear chromatin exhibiting two to 
five prominent nucleoli. Myeloblasts exhibit in the cytoplasm numerous mitochondria, 
Golgi bodies, scattered endoplasmic reticulum, and are devoid of granules.  
 
Promyelocyte 
The promyelocyte is characterized by the prominent production and 
accumulation of a large number of peroxidase-positive azurophil granules measuring 
~0.8 µm in diameter. Promyelocytes are also recognized by their large size (~15 µm), 
they have an extensive Golgi region, their nuclear features are very similar to those of 
myeloblasts, have fewer mitochondria than myeloblasts, and the endoplasmic reticulum 
is more fully developed. 
 
Myelocyte 
Myelocyte stage encompasses the period of most extensive morphologic 
alteration in neutrophil development, is the last mitotic stage, and is characterized by the 
production and accumulation of the peroxidase-negative specific (secondary) granules 
of 0.2-0.5 µm in diameter. The synthesis of larger azurophilic granules has ceased, and 
thereby their concentration decreases with mitotic divisions. Thus, myelocytes, which 
are smaller (~10 µm) than promyelocytes, show a mixed population of granules, namely 
the previously synthesized azurophils and the new specific granules which accumulate 
throughout the myelocyte stage and eventually come to outnumber the azurophils. 
Mitochondria decrease in number. The nucleus is reduced in size, round or oval and 
frequently eccentric, the nuclear chromatin appears more condensed and pyknotic, and 
the nucleus/cytoplasm ratio is decreased. The Golgi complex is large and contains 
forming specific granules. 
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Metamyelocyte 
The metamyelocyte as well as the subsequent mature development stages are 
nondividing phases, which are characterized by the nuclear morphology and mixed 
granule population. During the metamyelocyte (juvenile) stage the cytoplasm acquires 
the characteristics of mature neutrophils, and its most differentiating hallmark is nuclear 
indentation. The nuclear chromatin becomes coarsely clumped and condensed, while the 
nucleus becomes indented showing a kidney-bean shape, foretelling the first steps in 
nuclear segmentation. The metamyelocyte has lost the capacity for cell division, and 
further maturation consists predominantly of nuclear elongation and segmentation. 
 
Band granulocyte 
In the band (stab) stage, the indentation of the nucleus is more than half the 
diameter of the hypothetical round nucleus, and shares many morphological features of 
mature neutrophils. However, nuclear segmentation is not as pronounced as in mature 
PMNs and this is the major difference between these two stages. This is the first stage 
that may normally be found in the peripheral blood of normal people (~3-5% of the 
differential leukocyte count).   
 
Polymorphonuclear neutrophil 
Mature PMNs are recognized by a segmented nucleus with two to five, most 
frequently three, lobes that are connected by thin chromatin filaments. The chromatin is 
highly condensed. Morphologically mature PMNs show two distinct granule 
populations, a predominance of peroxidase-negative granules and peroxidase-positive 
azurophilic granules. The peroxidase-negative granule population includes three 
different entities, namely lactoferrin-enriched specific granules, gelatinase-enriched 
tertiary granules and secretory vesicles. 
  
HUMAN NEUTROPHIL GRANULES AND NEUTROPHIL HETEROGENEITY 
Peripheral blood neutrophils have been shown to be heterogeneous by several 
parameters, including locomotion, phagocytosis, oxidative metabolism, density, 
membrane potential, protein synthesis, and cell surface antigens 8. This neutrophil 
heterogeneity could reflect maturational differences, and there is evidence that 
functional heterogeneity operates at the level of cytoplasmic granules 9,10. Heterogeneity 
exists in both peroxidase-positive and peroxidase-negative cytoplasmic granules 10-12.  
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Human neutrophils contain an apparently releasable membrane-bound organelle 
type named secretory vesicle or phosphasome and three major functional types of 
granules, namely: azurophilic or primary granules, specific or secondary granules, and 
gelatinase-containing tertiary granules 6,13-16 (Table I). However, some proteins have 
been localized in additional cytoplasmic organelles that do not perfectly fit with the 
above mentioned major cytoplasmic granule populations, including organelles 
containing transforming growth factor-α 17, and vesicles containing tissue inhibitor of 
matrix metalloproteinases TIMP-1 18. Whether these subcellular locations reflect actual 
novel cytoplasmic granules or represent subpopulations of the above major neutrophil 
granules remain uncertain. 
 
Azurophil (primary) granules 
During granulocyte differentiation in the bone marrow, neutrophil precursors 
synthesize large amounts of lysosomal enzymes that are sequestered into azurophilic 
storage granules until used days later for digestion of phagocytized microorganisms 
after leukocyte emigration to inflamed tissues. Azurophilic granules first emerge at the 
promyelocyte stage, which are recognizable because of their large, prominent 
cytoplasmic granules that have a deep purple-red color in Wright-Giemsa-stained 
preparations. Thus, the term azurophil granule, given by early hematologists, is due to 
their affinity for the azure dyes of blood stains. These granules are also named primary 
granules, because they are the first granules produced in neutrophil development, or 
peroxidase-positive granules due to the presence of peroxidase in these organelles. 
Azurophil granules are the stores of all of the cellular myeloperoxidase and most 
proteolytic and bactericidal proteins, and therefore these granules have been considered 
as the microbicidal compartment mobilized during phagocytosis. Azurophil granule 
degranulation is confined primarily to internalized phagocytic vacuoles during 
phagocytosis 19, indicating that this granule is mainly involved in phagocytosis. The 
presence of myeloperoxidase in azurophil granules is of major importance for the proper 
oxygen-dependent bactericidal system of neutrophils as myeloperoxidase acts on H2O2 
made by the NADPH oxidase, generating highly toxic products. Myeloperoxidase and 
H2O2 form an enzyme-substrate complex that oxidizes halides to toxic agents (e.g.: 
hypochlorous, hypochlorite) which can attack cells in a variety of ways. Morphological 
and biochemical heterogeneity has been described within azurophil granules 10,11,20, and 
a subtype of azurophil granules is highly enriched in defensins but relatively deficient in 
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myeloperoxidase, β-glucuronidase, lysozyme, and elastase, typical markers of primary 
granules 11. Azurophil granules have been shown to contain large amounts of acid 
hydrolases, lysosomal enzymes and mannose 6-phosphate-containing glycoproteins, but 
no lysosome-associated membrane proteins (LAMP) 21,22, and thereby they cannot be 
classified as proper lysosomes. LAMPs are found in the membranes of multivesicular 
bodies (MVB), and multilaminar compartments (MLC), and they could be considered as 
the true lysosomes of resting PMNs 21,22. Azurophil granule proteins are of particular 
interest as some of them (proteinase-3, myeloperoxidase, bactericidal/permeability 
increasing protein -BPI-, elastase and cathepsin G) are now recognized as target 
antigens for antineutrophil cytoplasmic antibodies (ANCA), which are associated with 
severe autoimmune diseases 23,24. The abnormal giant granules of Chediak-Higashi 
syndrome neutrophils in humans originate from azurophil granules 25. 
 
Specific granules 
When human promyelocytes mature into myelocytes, many of the typical 
granulations lose their azurophilic properties and become neutrophilic, in that they are 
colored by both acidic and basic dyes. These neutrophilic granulations were called 
specific granules by early hematologists as they were specific for neutrophils and 
distinguished them from other granulocytes (eosinophils and basophils). Specific 
granules, which are peroxidase-negative, are also named as secondary granules because 
they are the second type of granules generated during neutrophil development, and 
ultimately outnumber the peroxidase-positive granules by more than two to one. 
Because specific granules contain four types of extracellular matrix receptors (laminin, 
fibronectin, and vitronectin receptors, and the receptor for C3bi/fibrinogen 
CD11b/CD18) they have been named as “adhesomes” 26. Specific and gelatinase-
containing tertiary granules share many protein constituents (Table I), suggesting that 
both granules play similar roles. 
 
Tertiary granules 
Tertiary granules were biochemically identified first in the eighties by 
subcellular fractionation studies as novel granule population entities by Marco 
Baggiolini’s group in Berne (Switzerland) 13 and by Donald L. Schneider and Faustino 
Mollinedo when they were at the Darmouth Medical School in Hanover (New 
Hampshire, USA) 14,15. Then, biochemical, functional and electron microscopy studies 
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further characterized these peroxidase-negative gelatinase-rich tertiary granules as 
readily mobilized granules containing proteins involved in adhesion, diapedesis, 
signaling and acidification 14,15,27-38. The constituents of tertiary granules as well as their 
prone exocytosis following neutrophil activation led us to postulate a mechanism by 
which neutrophil function can be regulated through mobilization of gelatinase-rich 
granules (Fig. 2) 27,33. Tertiary granules contain adhesion proteins (e.g.: CD11b/CD18) 
28,29 as well as heparanase and gelatinase, two major extracellular-matrix degradative 
enzymes involved in extravasation processes 38. Therefore, exocytosis of tertiary 
granules leads to the expression of cell-surface adhesion proteins and the release of 
extracellular-matrix degradative enzymes that constitute crucial processes for the 
attachment of neutrophils to the endothelium and subsequent extravasation, a process 
called diapedesis. Tertiary granules also contain cytochrome b558 14,32, the major 
component of the superoxide anion-generating NADPH oxidase, and the dominant 
location of a proton pump ATPase-acidification activity was in these granules 15. In this 
regard, fusion of tertiary granules with the phagocytic vacuoles could be suggested to be 
necessary for the proper function of acid hydrolases and the myeloperoxidase-H2O2-
halide antimicrobial system, which must act into the phagocytic vacuole following the 
subsequent fusion of azurophil granules. Thus, mobilization of tertiary granules seems 
to be a key process for both diapedesis and phagocytosis in human neutrophils (Fig. 2). 
Tertiary and specific granules, which have nearly identical densities, share a wide 
number of components although at different relative amounts 16,32,39,40, so that in tertiary 
granules gelatinase is predominant and in specific granules lactoferrin is the prevalent 
constituent. Specific and tertiary granules can be mobilized differentially under certain 
experimental conditions 32,35,41-43. Tertiary granule degranulation results in priming of 
neutrophils that involves the formation of an intermediate stage in cell activation 
27,35,42,44-46. Gelatinase granules are formed at the metamyelocyte and band cell stages 16, 
and may allow for exocytosis of gelatinase during neutrophil diapedesis without 
substantial mobilization of specific granules. However, a partial fusion of both 
gelatinase-containing tertiary granules 47 and specific granules 48 with the plasma 
membrane occurs during preparation of enucleated cytoplasts, vesicles devoid of 
granules consisting solely of cytoplasm surrounded by plasma membrane.  
The importance of specific and tertiary granules in neutrophil function come 
from the fact that patients with “specific granule deficiency” (SGD), a rare congenital 
disorder, suffer from frequent and severe bacterial infections 49,50. Neutrophils from 
  
11  
 
these patients display atypical bilobed nuclei; lack expression of at least one primary 
and all secondary and tertiary granule proteins; are unable to infiltrate into tissues; and 
possess defects in chemotaxis, disaggregation, receptor upregulation, and bactericidal 
activity. Although the first of five patients worldwide was reported in the early 1970s, 
the molecular basis for the defect was discovered only recently, and lies on the 
functional loss of the myeloid transcription factor CCAAT/enhancer binding protein ε 
(C/EBPε) 50. 
 
Secretory vesicles/phosphasomes 
Secretory vesicles, also named as alkaline phosphatase-containing granules or 
“phosphasomes”, have been described morphologically using albumin as a matrix 
marker 51-54 and alkaline phosphatase as a membrane marker 55-57. This organelle was 
identified and termed as “phosphasome” by Timothy J. Peters’ group in Harrow (UK) 
using a combination of analytical subcellular fractionation and electron microscopy 55, 
and by Niels Borregaard’s group in Copenhagen (Denmark), who named it as secretory 
vesicle, due to its extremely readiness to secretion 16,56,57. Alkaline phosphatase is 
present on the luminal side of the vesicles, and therefore the enzymatic activity in these 
particulates can only be assayed in the presence of a detergent (latent alkaline 
phosphatase) 56. Thus, measurement of alkaline phosphatase in the absence of detergent 
is used as a marker for plasma membrane, whereas measurement of latent alkaline 
phosphatase is a marker for secretory vesicles/phosphasomes. Despite difficulties in 
separating plasma membranes from secretory vesicles by density gradient 
centrifugation, a combination of density centrifugation with free flow electrophoresis 
allowed to characterize these organelles 46,58-61. The only known intravesicular 
components of secretory vesicles are plasma proteins, indicating that these organelles 
are endocytic in origin. Secretory vesicles are formed in band cells and mature PMNs 
by endocytosis 40. Secretory vesicles are apparently retained in the cell until it is 
stimulated, and are not reformed afterwards 40,51. However, it has been reported that 
once CR1 (CD35), a major maker for secretory vesicles, reaches the plasma membrane 
following secretory vesicle mobilization, it is rapidly internalised in small endocytic 
vesicles upon neutrophil activation 53. At present secretory vesicles are considered as 
small intracellular vesicles that fuse rapidly with the plasma membrane, discharging 
their contents to the external medium or to the phagosome lumen in response to an 
appropriate stimulus. Human neutrophils have been reported to be devoid of caveolin 
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and therefore secretory vesicles are not related to caveolae nor dependent on caveolae 
for mobilization 62. 
 
GRANULE BIOGENESIS 
The formation of human neutrophil granules during neutrophil maturation can be 
viewed as a continuum that reflects the differences in the time of biosynthesis of the 
various proteins that characterize each cytoplasmic granule 16. Thus, the individual 
regulation of granule protein mRNA levels during neutrophil maturation can explain the 
heterogeneity of the distinct neutrophil granule subsets 63. The granules formed at any 
particular stage of neutrophil development will be made up of granule proteins 
synthesized at that specific time, i.e., granule proteins will be incorporated into the type 
of granules formed in each particular stage of neutrophil maturation 16. Thus, the 
different subsets of neutrophil granules are the result of differences in the biosynthetic 
time windows of the various granule proteins during maturation and not the result of 
specific sorting between individual granule subsets 16. The control of the expression of 
genes encoding for the distinct granule proteins is exerted by transcription factors that 
are turned on and off at different times during neutrophil maturation. In vitro and in vivo 
experiments have shown that some transcription factors, such as C/EBPα and acute 
myeloid leukemia 1 (AML-1), play important roles during early differentiation of 
granulocytes (granulopoiesis) 16,64-66, whereas others, such as C/EBPε and CCAAT 
displacement protein (CDP), exert their function in more mature neutrophil precursors 
16,66,67. C/EBPε is essential for secondary and tertiary granule protein expression 50,67-69. 
In the bone marrow of C/EBPε(-/-) mice, lactoferrin and neutrophil gelatinase 
expression is absent, further supporting that C/EBPε is essential for the expression of 
neutrophil secondary and tertiary granule genes 69. These mice express C/EBPα, 
C/EBPβ, and C/EBPδ in the bone marrow at levels similar to those of their wild-type 
counterparts, suggesting a lack of functional redundancy among the family members in 
vivo 69. 
 
DIFFERENTIAL GRANULE MOBILIZATION AND DIFFERENT TYPES OF 
EXOCYTOSIS 
Exocytosis plays an important role in neutrophil physiology, and secretion of 
readily mobilizable granules seems to regulate early neutrophil responses, including 
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adhesion, extravasation and the onset of respiratory burst 16,33. The three major 
neutrophil granules are differentially mobilized upon cell activation. Azurophilic 
granules are sluggishly mobilized upon neutrophil activation, whereas specific and 
tertiary are readily exocytosed following neutrophil activation 27,33,38,56,70. The rank 
order of exocytosis following a ionophore-induced progressive elevation of cytosolic 
calcium 70, and during in vivo exudation of neutrophils into skin chambers 71 is 
gelatinase-containing tertiary granules, specific granules, and azurophil granules, clearly 
illustrating a hierarchy in granule mobilization. Azurophilic granules contain a large 
number of lytic enzymes that can be detrimental to the surrounding tissue if secreted in 
a deregulated way, and they are mostly involved in phagocytosis, secreting their 
contents into the phagosomes. Specific and tertiary granules are mainly involved in 
secretion, contain a wide array of proteins involved in human neutrophil adhesion and 
extravasation, and constitute a reservoir of plasma membrane proteins that are 
translocated to the cell surface upon neutrophil activation 14,16,26,28-30,33,34,36,38,70. 
In principle, exocytosis of cytoplasmic granules can be envisioned to proceed 
through three major mechanisms or a combination of these (Fig. 3): a) simple 
exocytosis, when each granule fuses independently of each other with the plasma 
membrane; b) compound exocytosis, when two or more granules fuse with each other in 
the cytosol prior to their fusion with the plasma membrane; c) cumulative fusion, when 
one granule fuses initially with the plasma membrane, and subsequently additional 
granules fuses with the granule already engaged in fusion, thus forming a so-called 
degranulation sac 72. Compound exocytosis and cumulative fusion have been 
demonstrated to occur in eosinophils 72-74. Compound exocytosis and cumulative fusion 
could serve to direct and concentrate the released granule content to a focused area, thus 
enhancing the local concentration of the released products and potentiating their 
functional effects. In this regard, it has been reported the formation of CR3 membrane 
domains during immune recognition in human neutrophils, very likely by fusion of 
CR3-bearing granules at local sites of adhesion 75. It has been recently reported 76 by 
patch-clamp capacitance measurements and electron microscopy that the prevailing 
mechanism of exocytosis in human neutrophils seems to be simple exocytosis 
intermingled with compound exocytic events, whereas cumulative fusion seems to be a 
more rare event. However, although compound exocytosis is a rather infrequent event, it 
has been suggested that the number of granules that merge into a compound granule 
might be high, such that the number of receptors up-regulated and matrix proteins 
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released by this mechanism could be close to 25% in human neutrophils 76. In addition, 
electron microscopy evidence has been shown for a predominant cumulative fusion 
process in rabbit neutrophils stimulated with formyl-Met-Leu-Phe (fMLP) in 
combination with cytochalasin B 77. 
 
SNARE PROTEINS AS MAJOR REGULATORS OF NEUTROPHIL 
EXOCYTOSIS 
The membrane fusion process requires a molecular mechanism in order to 
juxtapose and fuse the two membranes involved, and a regulatory mechanism that 
confers specificity to a particular type of fusion. In neuronal tissue and other systems, 
fusion of a vesicle with its target membrane is mainly mediated by a set of proteins 
collectively referred to as SNAREs (soluble NSF-attachment protein (SNAP) receptors; 
NSF is N-ethylmaleimide-sensitive factor) 78. The SNARE hypothesis, initially 
postulated for synaptic vesicle release in the neuronal system, assumes that docking and 
fusion of vesicles with the plasma membrane is mediated by the specific interaction of 
proteins on the vesicle cell membrane (v-SNAREs) with target plasma membrane-
located proteins (t-SNAREs) 79. Both v- and t-SNAREs seem to be required on 
opposing membranes for membrane fusion 80. v-SNAREs are type II integral membrane 
proteins located on vesicles facing the cytososl, and their prototype is the synaptic 
vesicle membrane protein synaptobrevin, also named vesicle-associated membrane 
protein (VAMP). t-SNAREs are membrane proteins that are associated with target 
membranes and are oriented toward the cytoplasm. The prototypes of t-SNAREs are 
syntaxin and the 25-kD synaptosome-associated protein (SNAP-25) 79. SNAP-25 is 
mainly detected in neuronal tissues 81, but its presence in non-neuronal cells has also 
been reported 82,83. Another protein named SNAP-23 (23-kD synaptosome-associated 
protein) 84, showing five isoforms A-E arised by alternative splicing 85,86, seems to fulfil 
the role of SNAP-25 in non-neuronal mammalian cells. To date eighteen syntaxins, 
eight VAMPs, SNAP-23, SNAP-25, SNAP-29 and SNAP-91, many of them showing 
additional alternative splicing variants, have been described in mammalian systems. 
The neuronal SNAREs VAMP-2, syntaxin 1A and SNAP-25 have been shown 
to assemble into a very stable ternary complex with a 1:1:1 stoichiometry, referred to as 
the core complex, that consists of a twisted four-helical bundle (VAMP-2 and syntaxin 
1A contributing with one α-helix each and SNAP-25 contributing with two α-helices) 
with all the chains aligned in parallel 87. In the last years, a wide number of additional 
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SNARE proteins have been identified, some of these are only distantly related to the 
three neuronal “founding members” of the v- and t-SNARE families and cannot be 
easily assigned to one specific group. However, sequence comparison analyses have 
showed that all SNAREs share a homologous domain of ~60 amino acids, referred to as 
the SNARE motif 88-90, that mediates the association of SNAREs into core complexes 
forming the above four-helical bundle. All known SNARE motifs fall into two major 
subfamilies that contain either a conserved glutamine (Q-SNARE) or a conserved 
arginine (R-SNARE) at a central position, leading to a reclassification of SNARE 
proteins into Q- and R-SNAREs 88. The v-/t-SNARE terminology, based on their 
respective localization and overall structure, is very intuitive and illustrative on the 
corresponding location of the proteins involved in the fusion process. However, the 
classification into Q- and R-SNAREs, based on their contribution to the ionic layer of 
SNARE complex, seems to be more accurate as the localization on trafficking vesicles 
or target membranes does not always correlate with structurally identified SNARE 
subfamilies. Thus, SNAP-23, a widely considered t-SNARE, has been mainly located in 
cytoplasmic granules in human neutrophils, acting as a v-SNARE in this cell type 3, and 
has been also found in intracellular compartments in additional cell types 91,92. In the 
neuronal SNARE complex, three glutamine residues from the Q-SNARE motifs (one 
contributed by syntaxin 1A and two by SNAP-25) and one arginine residue from the R-
SNARE motif (contributed by VAMP-2) form an ionic layer in the four-helical bundle 
87. Neuronal SNARE complex seem to be paradigmatic for all SNARE complexes, and 
thereby most of the SNARE complexes involved in membrane fusion consist of four-
helix bundles, formed from three Q-SNAREs and one R-SNARE [3 (Q-SNARE)/1 (R-
SNARE) type] 78.  
Recently, we and others 3,4,83,85,93-95 have demonstrated the presence of a number 
of SNAREs in human neutrophils as well as in the neutrophil cell culture model HL-60 
cell line 96 by genetic and immunological approaches. Table II shows the SNARE 
proteins that are expressed in both human peripheral blood neutrophils and HL-60 cells. 
In addition, we have found evidence that human neutrophils and neutrophil-like 
differentiated HL-60 cells (HL-60 neutrophils) express two isoforms of SNAP-23 (A 
and B) 85 as well as two isoforms of syntaxin 3 (A and B) 94. SNAP23 gene can generate 
two types of messages in human neutrophils, the full-length message (SNAP23A) and a 
shorter message (SNAP23B) 85. This latter is the result of alternative splicing where 
exon 5 is joined to exon 7, skipping exon 6 97. The novel SNAP-23B isoform results 
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from a deletion of 159 bp of the SNAP-23A cDNA leading to a protein identical to 
SNAP-23A (211 amino acid residues), but lacking 53 amino acid residues, from 90 to 
142 85. Subsequently three new minor alternative-splicing-derived SNAP-23 variants 
(SNAP-23 C, D and E) have been described 86. Nevertheless, SNAP-23A is the major 
isoform expressed in human neutrophils 85, and thereby it will be referred to as SNAP-
23 in this review. Syntaxin 3A is identical to the previously reported syntaxin 3, and the 
novel isoform syntaxin 3B is identical to syntaxin 3A but lacks 37 amino acid residues 
at the carboxy-terminal region and is expressed at much lower levels than syntaxin 3A 
94. A syntaxin 4 precursor, containing an intron of 136 nucleotides as a result of an 
incomplete RNA splicing, has been detected by RT-PCR in human neutrophils 94. This 
syntaxin 4 precursor is also accumulated during neutrophil differentiation of HL-60 
cells 94. The accumulation of an RNA splicing intermediate could suggest the putative 
existence of a regulatory mechanism at the level of RNA splicing, acting as a rate-
limiting step in modulating the levels of syntaxin 4 during neutrophil development and 
in mature neutrophils. The presence of a syntaxin 4 splicing intermediate with an intron 
of 136 nucleotides might reflect a limiting step in the processing of this gene RNA, 
perhaps related to the large structure of the spliceosome complex 98 and the small size of 
this intron. 
Human neutrophils are terminal non-proliferating cells that have a reduced 
capacity of macromolecule biosynthesis 99, but exhibit a prominent secretory capacity 
16,33. Accordingly, the cytoplasm of these short-lived, highly specialized phagocytes is 
full of cytoplasmic granules, many of them readily exocytosed on cell activation 16,33. 
Neutrophil differentiation of human leukemic HL-60 cells mimics some of the changes 
observed during neutrophil maturation in bone marrow 96,100-102. Thus, an increased 
expression of some genes during HL-60 neutrophil differentiation could suggest a more 
specialized role for these gene products in mature cells. We have found that syntaxin 7 
mRNA levels were negligible in undifferentiated HL-60 cells, and its expression was 
dramatically induced during neutrophil differentiation of these cells 94. This indicates 
that expression of syntaxin 7 is highly regulated during neutrophil differentiation and 
suggests a putative role for syntaxin 7 in some specialized functions of mature 
neutrophils. Likewise, similar specialized roles in mature neutrophils could be 
putatively assigned to SNAP-23, syntaxins 3, 4, 6 and 11, as well as to VAMP-2 which 
are also up-regulated during neutrophil differentiation of HL-60 cells 85,94,95. 
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In human neutrophils the Q-SNARE SNAP-23 and the R-SNARE VAMP-2 
have been mainly localized to the membranes of cytoplasmic granules, acting as v-
SNAREs, whereas syntaxins 4 and 6 (Q-SNAREs) have been found on the plasma 
membrane, acting as t-SNAREs 3,4,83,93,94. Thus, neutrophils contain all the components, 
v-SNAREs and t-SNAREs as well as Q- and R-SNAREs, required by the SNARE 
hypothesis and therefore SNARE proteins could play a role in regulated secretion in 
these cells. The first evidence for the functional involvement of SNARE proteins in 
regulating exocytosis of neutrophil cytoplasmic granules was achieved by cloning 
human syntaxin 6 3 and the subsequent functional characterization of syntaxin 6 and 
SNAP-23 in human neutrophils 3. Human syntaxin 6, identified as a 255-amino acid 
protein with a carboxy-terminal transmembrane region and two coiled-coil domains, was 
mainly localized in the plasma membrane of human resting neutrophils. SNAP-23 was 
primarily located in the mobilizable tertiary and specific granules in resting human 
neutrophils, and then translocated to the cell surface, colocalizing with syntaxin 6, upon 
neutrophil activation conditions that rapidly mobilized tertiary and specific granules to the 
cell surface, whereas azurophilic granules were hardly mobilized. In addition SNAP-23 
and syntaxin 6 were found to interact both in vitro and in vivo, and the in vivo interaction 
was dramatically increased upon cell activation. Antibodies against SNAP-23 inhibited 
Ca2++GTP-γ-S-induced exocytosis of both CD66b-enriched specific and tertiary granules, 
but hardly affected exocytosis of the CD63-enriched azurophil granules, when introduced 
into electropermeabilized neutrophils.  Anti-syntaxin 6 antibodies prevented exocytosis of 
both CD-66b- and CD63-enriched granules in electropermeabilized neutrophils. Thus, 
syntaxin 6, acting as a t-SNARE, and SNAP-23, acting as a v-SNARE, are involved in 
human neutrophil exocytosis, demonstrating that vesicle v-SNARE-t-SNARE interactions 
modulate neutrophil secretion. Interestingly, syntaxin 6 acts as a target for secretion of 
specific, tertiary and azurophil granules, whereas SNAP-23 mediates only specific and 
tertiary granule secretion. This indicates that different secretory granules in the same cell 
with different secretory properties use distinct but overlapping proteins for secretion. 
Furthermore, we have very recently demonstrated that VAMP-2, localized in the 
membranes of specific and gelatinase-containing tertiary granules in resting human 
neutrophils, mediates also exocytosis of these cytoplasmic granules via its interaction 
with plasma membrane syntaxin 4 4. The presence of SNAP-23 and VAMP-2 in the 
readily mobilizable specific and gelatinase-containing tertiary granules, but not in the 
sluggishly mobilized azurophil granules, leads us to postulate that the selective presence 
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of certain SNAREs in distinct granule membranes might explain the different 
mobilization of neutrophil granule populations during cell activation 3,4,94.  
Our recent data show that specific antibodies against VAMP-2, syntaxin 4, 
syntaxin 6 and SNAP-23 inhibit secretion of CD66b-positive specific and gelatinase-
containing tertiary granules, suggesting that VAMP-2 and SNAP-23, acting as v-
SNAREs, and syntaxin 4 and syntaxin 6, acting as t-SNAREs, are involved in the 
regulation of exocytosis of both tertiary and specific granules 3,4. Because current 
evidence suggests that neuronal SNARE complexes involved in membrane fusion 
consist of four-helix bundles, formed from three Q-SNAREs and one R-SNARE [3 (Q-
SNARE)/1 (R-SNARE) type] 78, we could envisage a hypothetical model in which two 
3 (Q-SNARE)/1 (R-SNARE) type ternary complexes, containing syntaxin 4/SNAP-
23/VAMP-2 and syntaxin 6/SNAP-23/VAMP-2, respectively, would be required for 
exocytosis of neutrophil tertiary or specific granules (Fig. 4). These complexes could 
involve the interaction of Q-SNAREs (syntaxin 4, syntaxin 6, SNAP-23) with the R-
SNARE VAMP-2, forming two different 3 (Q-SNARE)/1 (R-SNARE) ternary 
complexes. SNAP-23 would contribute with two SNARE motifs, and thereby two 
glutamines within the central part of the SNARE motifs, in the four-helix bundle of the 
SNARE core complex, whereas syntaxin 4, syntaxin 6 and VAMP-2 would contribute 
with one SNARE motif each. This model explains that both tertiary and specific 
granules are secreted in a rather similar way, and in fact, exocytosis of specific granules 
is not observed without exocytosis of tertiary granules. The differential location of 
SNARE proteins in readily mobilized granules (specific and tertiary granules) versus 
sluggishly mobilized granules (azurophil granules) can be of major importance to 
differentially regulate mobilization of neutrophil granules with distinct exocytic 
capabilities and functions. Interestingly, we have detected VAMP-2 at the granule 
membrane on the adjoining sides of two contacting granules 4, suggesting that VAMP-2 
could be also involved in granule-granule fusion processes that can take place during 
either compound exocytosis 72 or endocytosis. The composition of SNARE proteins is 
very similar, if not identical, between the so-called secretory granules (specific and 
tertiary granules) and different from azurophil granules 3,4. This suggests that qualitative 
differences occur between the sets of membrane proteins present in both azurophil and 
secretory granules with a high disparity in their respective exocytic capabilities, but 
subtle differences in the mobilization of the distinct secretory granule subsets, such as 
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between specific and tertiary granules, may be very likely due to quantitative 
differences in the appropriate proteins rather than to qualitative differences. 
 Interestingly, a novel human kinase SNAK (SNARE kinase) that specifically 
phosphorylates SNAP-23 has been identified, and SNAP-23 phosphorylation by SNAK 
enhances the kinetics of its assembly into SNARE complexes in vivo 103. This adds 
another regulatory event at the exocytic process. 
During exocytosis in human neutrophils, SNARE proteins of secretory granules 
interact with the corresponding SNARE proteins in the plasmalemma to initiate the 
fusion reaction. However, it remains uncertain whether SNAREs are uniformly 
distributed in the membrane or whether specialized fusion sites exist. SNARE proteins 
have been found in other cell types to be concentrated in 200 nm large, cholesterol-
dependent clusters at which secretory vesicles preferentially dock and fuse, suggesting 
that high local concentrations of SNAREs are required for efficient fusion 104. SNAP-
23, which is palmitoylated in vivo on one or more cysteine residues present in a central 
"palmitoylation domain” 105, has been found to be localized in membrane rafts in PC12 
cells and 3T3-L1 adipocytes 106,107. SNAP-23 distribution seem to be distinct from 
caveolin-1, and clusters of SNAP-23 are dispersed after cholesterol extraction with 
methyl-beta-cyclodextrin, suggesting that the majority of SNAP-23 is associated with 
non-caveolar, cholesterol-rich lipid rafts 107. In 3T3-L1 adipocytes, a significant 
proportion of syntaxin 4 has been also found in membrane rafts together with SNAP-23, 
whereas VAMP-2 was concentrated in lipid rafts isolated from intracellular membranes, 
and insulin stimulation had no effect on the plasma membrane raft association of 
SNAP-23 or syntaxin 4 but promoted VAMP-2 insertion into plasma membrane rafts 
107. These data implicate lipid rafts as important platforms for insulin-dependent Glut4 
vesicle fusion and suggest the hypothesis that such rafts may represent a spatial 
integration point of insulin signaling and membrane traffic 107. Additional SNARE 
proteins have been found to be located in membrane rafts in different systems 104,106,108-
111. On these grounds it is tempting to suggest that the interaction of SNARE proteins 
with lipid rafts could be important to direct exocytosis in human neutrophils, allowing 
structural and spatial organization of the secretory machinery, serving as a scaffold for 
proteins involved in the secretion of the distinct cytoplasmic granules, and drawing the 
exocytic events to rather specialized areas of the cell surface. 
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RABS AND SYNAPTOTAGMINS AS PUTATIVE SNARE REGULATORS IN 
NEUTROPHIL EXOCYTOSIS 
The SNARE-mediated membrane fusion process is thought to be regulated by a 
number of different proteins, including Rab proteins and synaptotagmins 112,113. Rab 
proteins constitute the largest family of monomeric small GTPases present in the 
cytosol which can confer specificity on the SNARE interactions 114. The molecular 
interactions between Rab effectors and components of the SNARE machinery as well as 
of the exocytic pathway, such as cytoskeleton  that is required for neutrophil exocytosis 
115,116, provides a framework of how Rab proteins could affect SNARE-mediated 
exocytosis. Rabs as well as other small GTPases function as molecular switches that 
alternate between GTP- and GDP-bound conformations. The active GTP-form/inactive 
GDP-form cycle imposes temporal and spatial regulation to membrane transport, and 
Rab proteins can act like timers that are set depending on the rates of nucleotide 
exchange and hydrolysis. The on/off regulatory function of Rab, as well as of other 
small GTPases, is restricted to the membrane compartment where it is localized through 
the covalent attachment of a prenyl group. An important feature of Rab function lies in 
the fact that Rab proteins and effectors are not randomly distributed on the membrane, 
but are spatially clustered and segregated in a defined functional membrane domain or 
Rab domain 112, which seems to be different from sphingolipid and cholesterol-enriched 
lipid membrane rafts 117. This allows to recruit in specific domains a wide number of 
Rab effectors and downstream proteins involved in membrane docking and fusion that 
could promote oligomerization of proteins and the formation of scaffolds in which 
cytoskeletal tracks can be anchored to increase the efficiency of vesicle-target 
membrane fusion. 
Rab5a has been identified in human neutrophils 118, and found to be a key 
regulator of phagolysosome maturation in human neutrophils 119. In addition CR1 
(CD35)-rich secretory vesicles from resting human neutrophils have been found to 
constitutively copurify with Rabs 3a, 4, and 5a, and reversibly bind an ARF, likely 
ARF1 120, suggesting a role for these proteins in regulating the transport of these 
organelles. Undifferentiated HL-60 cells express several Rab proteins that are 
upregulated following neutrophil differentiation with DMSO, but none of these proteins 
was located at the specific or azurophilic granules in human neutrophils 121.  
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Synaptotagmins are a family of calcium and phospholipid-binding membrane 
proteins that might function as Ca2+-sensors triggering exocytosis in a Ca2+-dependent 
manner, and have been found on regulated secretory vesicles in neurons and other 
secretory cell tissues 113. In addition there are indications that synaptotagmin-SNARE 
interactions function during exocytosis 122. Because the distinct neutrophil cytoplasmic 
granules have different Ca2+ requirements for secretion, the azurophilic granules are 
only secreted at high Ca2+ concentration whereas secondary granules are secreted at 
lower Ca2+ concentration 70,123, it can be suggested the existence of putative calcium 
sensors responsible for the differential mobilization of distinct neutrophil granules. In 
this regard, synaptotagmin II has been recently reported to be present in human 
neutrophils 124 as a protein of 80 kD using a monoclonal antibody raised against the N-
terminal portion of synaptoptagmin II. However, this antibody recognized a band of 
about 60 kD in rat brain membrane preparations, suggesting that the higher molecular 
weight synaptotagmin II found in neutrophils could be due to posttranslational 
modifications or to alternative splicing during neutrophil differentiation 124. These 
authors also found that synaptotagmin II was associated with specific granules in resting 
human neutrophils and translocated to the cell surface upon cell activation, as well as to 
the phagosome after complement-mediated phagocytosis in the presence of calcium, 
suggesting a role for synaptotagmin II as a calcium-sensor during phagocytosis and 
secretion in neutrophils 124.   
 
ADDITIONAL PUTATIVE PROTEINS INVOLVED IN NEUTROPHIL 
EXOCYTOSIS  
It is likely that additional proteins, including different small GTPases and 
annexins could control the exocytic pathway in human neutrophils. The involvement of 
“small G-proteins” in exocytosis is suggested by the demonstration that, in 
permeabilized neutrophils, guanine nucleotides stimulate degranulation through a 
mechanism distinct from the stimulation of the “large G-proteins” involved in the 
transduction of activation signals across the plasma membrane 125. Exocytosis can be 
initiated in neutrophils by guanine nucleotides in a pertussis toxin-insensitive manner 
and in the absence of phospholipase C activity or Ca2+ mobilization 126. Distinct subsets 
of low molecular weight GTP-binding proteins have been associated with the 
membranes of neutrophil specific and azurophil granules, suggesting that this could be 
related to a differential regulation during exocytosis of these two compartments 127. 
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Neutrophils contain a large number of Ras-related GTP-binding proteins 128,129, and 
some of these proteins have been located into readily mobilized neutrophil granules, 
namely Rap1 and Rap2 in both specific and tertiary granules 130,131, suggesting a 
putative role in the mobilization of these organelles upon neutrophil activation. 
Differences in the Ca2+ concentrations required to exocytose distinct granule 
populations suggest the existence of Ca2+ sensors regulating their mobilization, and 
thereby it is plausible that synaptotagmins, annexins or additional Ca2+-binding proteins 
could play a role in granule fusion processes. Annexins are soluble proteins that bind to 
phospholipid membranes in a calcium-dependent manner and have been putatively 
involved in granule fusion processes. Annexins I, II, III, IV, VI and XI have been found 
to be translocated to neutrophil granules in a Ca2+-dependent way 132-137. Annexin III, a 
33 kDa protein mainly expressed in neutrophils, aggregates granules in cell-free assays, 
and translocates to the plasma or phagosome membrane upon cell stimulation or when 
neutroghils ingest opsonized yeast 134,138. Interestingly, different Ca2+ concentrations are 
required for binding of annexins to the distinct granule subsets 135. A non-annexin Ca2+-
binding protein, identified as grancalcin, has been found to be translocated selectively to 
secretory vesicles 133. Furthermore, phospholipase D in conjuction with annexin I is 
capable of promoting the aggregation of granules and artificial membranes 139. 
 
CONCLUDING REMARKS 
Neutrophil is able to secrete granule constituents and regulate the expression and 
activity of cell surface receptors and proteins through fusion of cytoplasmic granules 
with the plasma membrane, exposing new proteins at the cell surface or replenishing 
additional ones. These secretory events are of major relevance for the inflammatory role 
of human neutrophils. The different cytoplasmic granules present in human neutrophils 
can be clustered in two major groups concerning their exocytic capabilities. Peroxidase-
positive (azurophil) granules, mainly involved in phagocytosis, that are sluggishly 
mobilized upon cell activation, and peroxidase-negative granules (specific and tertiary 
granules), mainly involved in exocytosis, which constitute an easily mobilizable 
population of cytoplasmic storage organelles that are mobilized to the cell surface 
following stimulation. The location of a number of membrane receptors and soluble 
proteins in several intracellular compartments with subtle differences in mobilization, 
such as specific and tertiary granules, ensures a graded upregulation and secretion of 
these proteins in response to stimulation that could lead to a more lasting and graded 
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response. The involvement of SNARE proteins in neutrophil exocytosis provides the 
basis to understand the molecular events controlling neutrophil exocytosis, and gives for 
the first time a molecular explanation for the differential mobilization of both 
peroxidase-negative and peroxidase-positive granules. Specific and tertiary granules 
share a similar set of SNARE proteins in their membranes that differ from that of 
azurophil granules, suggesting that different combinations of SNARE proteins regulate 
exocytosis of the distinct cytoplasmic granules in human neutrophils. The subtle 
differences in secretion found between specific and tertiary granules could be due to 
quantitative rather than to qualitative differences in the machinery controlling their 
respective exocytosis. Additional SNARE-interacting proteins are suggested to play a 
role in neutrophil exocytosis, and this will constitute a subject of major interest for 
future experimentation. Since exocytosis plays a key role in neutrophil physiology, 
elucidation of the molecular mechanisms of neutrophil secretion is of major 
pharmacological interest and can provide novel therapeutic targets for anti-
inflammatory agents. 
 
ACKNOWLEDGEMENTS 
  This work was supported by grants FIS-01/1048 and FIS-02/1199 from the 
Fondo de Investigación Sanitaria and grant SA-087/01 from Junta de Castilla y León. 
The author is indebted to the previous and present members of his laboratory who 
contributed with much of the work that has made this review possible (Pedro M. Lacal, 
Jesús Balsinde, Rafael Pulido, Dolores Collado-Escobar, Consuelo Gajate, Belén 
Martin-Martín, and Antonio Santos-Beneit). 
 
 
REFERENCES 
1. Mollinedo F, Borregaard N, Boxer LA. Novel trends in neutrophil structure, 
function and development. Immunol Today 1999; 20: 535-537. 
2. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli 
L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 
2000; 80: 617-653. 
3. Martin-Martin B, Nabokina SM, Blasi J, Lazo PA, Mollinedo F. Involvement of 
SNAP-23 and syntaxin 6 in human neutrophil exocytosis. Blood 2000; 96: 2574-
2583. 
4. Mollinedo F, Martin-Martin B, Calafat J, Nabokina SM, Lazo PA. Role of 
vesicle-associated membrane protein-2, through q-soluble N- ethylmaleimide-
sensitive factor attachment protein receptor/r-soluble N- ethylmaleimide-
sensitive factor attachment protein receptor interaction, in the exocytosis of 
  
24 
  
specific and tertiary granules of human neutrophils. J Immunol 2003; 170: 1034-
1042. 
5. Fossati G, Moulding DA, Spiller DG, Moots RJ, White MR, Edwards SW. The 
mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, 
respiratory burst activation, and commitment to apoptosis. J Immunol 2003; 
170: 1964-1972 
6. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic 
polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971; 134: 
907-934. 
7. Wright DG: The neutrophil as a secretory organ of host defense. Phagocytic 
cells. Edited by Gallin JI, Fauci AS. New York, NY, Raven Press, 1982, pp 75-
110 
8. Gallin JI. Human neutrophil heterogeneity exists, but is it meaningful? Blood 
1984; 63: 977-983. 
9. Gallin JI. Neutrophil specific granules: a fuse that ignites the inflammatory 
response. Clin Res 1984; 32: 320-328. 
10. Rice WG, Kinkade JM, Jr., Parmley RT. High resolution of heterogeneity 
among human neutrophil granules: physical, biochemical, and ultrastructural 
properties of isolated fractions. Blood 1986; 68: 541-555. 
11. Rice WG, Ganz T, Kinkade JM, Jr., Selsted ME, Lehrer RI, Parmley RT. 
Defensin-rich dense granules of human neutrophils. Blood 1987; 70: 757-765. 
12. Gilbert CS, Parmley RT, Rice WG, Kinkade JM, Jr. Heterogeneity of 
peroxidase-positive granules in normal human an Chediak-Higashi neutrophils. J 
Histochem Cytochem 1993; 41: 837-849. 
13. Dewald B, Bretz U, Baggiolini M. Release of gelatinase from a novel secretory 
compartment of human neutrophils. J Clin Invest 1982; 70: 518-525. 
14. Mollinedo F, Schneider DL. Subcellular localization of cytochrome b and 
ubiquinone in a tertiary granule of resting human neutrophils and evidence for a 
proton pump ATPase. J Biol Chem 1984; 259: 7143-7150. 
15. Mollinedo F, Manara FS, Schneider DL. Acidification activity of human 
neutrophils. Tertiary granules as a site of ATP-dependent acidification. J Biol 
Chem 1986; 261: 1077-1082. 
16. Borregaard N, Cowland JB. Granules of the human neutrophilic 
polymorphonuclear leukocyte. Blood 1997; 89: 3503-3521. 
17. Calafat J, Janssen H, Stahle-Backdahl M, Zuurbier AE, Knol EF, Egesten A. 
Human monocytes and neutrophils store transforming growth factor-alpha in a 
subpopulation of cytoplasmic granules. Blood 1997; 90: 1255-1266. 
18. Price B, Dennison C, Tschesche H, Elliott E. Neutrophil tissue inhibitor of 
matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the 
phagosome. J Biol Chem 2000; 275: 28308-28315. 
19. Leffell MS, Spitznagel JK. Fate of human lactoferrin and myeloperoxidase in 
phagocytizing human neutrophils: effects of immunoglobulin G subclasses and 
immune complexes coated on latex beads. Infect Immun 1975; 12: 813-820. 
20. Parmley RT, Gilbert CS, Boxer LA. Abnormal peroxidase-positive granules in 
"specific granule" deficiency. Blood 1989; 73: 838-844. 
21. Cieutat AM, Lobel P, August JT, Kjeldsen L, Sengelov H, Borregaard N, 
Bainton DF. Azurophilic granules of human neutrophilic leukocytes are 
deficient in lysosome-associated membrane proteins but retain the mannose 6- 
phosphate recognition marker. Blood 1998; 91: 1044-1058. 
  
25  
 
22. Bainton DF. Distinct granule populations in human neutrophils and lysosomal 
organelles identified by immuno-electron microscopy. J Immunol Methods 
1999; 232: 153-168. 
23. Zhao MH, Short AK, Lockwood CM. Antineutrophil cytoplasm autoantibodies 
and vasculitis. Curr Opin Hematol 1995; 2: 96-102. 
24. Witko-Sarsat V, Halbwachs-Mecarelli L, Almeida RP, Nusbaum P, Melchior M, 
Jamaleddine G, Lesavre P, Descamps-Latscha B, Gabay JE. Characterization of 
a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its 
reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Lett 1996; 
382: 130-136. 
25. Kjeldsen L, Calafat J, Borregaard N. Giant granules of neutrophils in Chediak-
Higashi syndrome are derived from azurophil granules but not from specific and 
gelatinase granules. J Leukoc Biol 1998; 64: 72-77. 
26. Singer, II, Scott S, Kawka DW, Kazazis DM. Adhesomes: specific granules 
containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in 
human polymorphonuclear leukocytes and monocytes. J Cell Biol 1989; 109: 
3169-3182. 
27. Mollinedo F, Schneider DL. Intracellular organelle motility and membrane 
fusion processes in human neutrophils upon cell activation. FEBS Lett 1987; 
217: 158-162. 
28. Lacal P, Pulido R, Sanchez-Madrid F, Mollinedo F. Intracellular location of 
T200 and Mo1 glycoproteins in human neutrophils. J Biol Chem 1988; 263: 
9946-9951. 
29. Lacal P, Pulido R, Sanchez-Madrid F, Cabanas C, Mollinedo F. Intracellular 
localization of a leukocyte adhesion glycoprotein family in the tertiary granules 
of human neutrophils. Biochem Biophys Res Commun 1988; 154: 641-647. 
30. Mollinedo F, Gomez-Cambronero J, Cano E, Sanchez-Crespo M. Intracellular 
localization of platelet-activating factor synthesis in human neutrophils. 
Biochem Biophys Res Commun 1988; 154: 1232-1239. 
31. Jones DH, Schmalstieg FC, Dempsey K, Krater SS, Nannen DD, Smith CW, 
Anderson DC. Subcellular distribution and mobilization of MAC-1 
(CD11b/CD18) in neonatal neutrophils. Blood 1990; 75: 488-498 
32. Mollinedo F, Gajate C, Schneider DL. Cytochrome b co-fractionates with 
gelatinase-containing granules in human neutrophils. Mol Cell Biochem 1991; 
105: 49-60. 
33. Mollinedo F, Pulido R, Lacal PM, Sanchez-Madrid F. Mobilization of 
gelatinase-rich granules as a regulatory mechanism of early functional responses 
in human neutrophils. Scand J Immunol 1991; 34: 33-43. 
34. Balsinde J, Diez E, Mollinedo F. Arachidonic acid release from diacylglycerol 
in human neutrophils. Translocation of diacylglycerol-deacylating enzyme 
activities from an intracellular pool to plasma membrane upon cell activation. J 
Biol Chem 1991; 266: 15638-15643. 
35. Kjeldsen L, Bjerrum OW, Askaa J, Borregaard N. Subcellular localization and 
release of human neutrophil gelatinase, confirming the existence of separate 
gelatinase-containing granules. Biochem J 1992; 287: 603-610. 
36. Mollinedo F, Burgaleta C, Velasco G, Arroyo AG, Acevedo A, Barasoain I. 
Enhancement of human neutrophil functions by a monoclonal antibody directed 
against a 19-kDa antigen. J Immunol 1992; 149: 323-330. 
  
26 
  
37. Kjeldsen L, Sengelov H, Lollike K, Nielsen MH, Borregaard N. Isolation and 
characterization of gelatinase granules from human neutrophils. Blood 1994; 83: 
1640-1649. 
38. Mollinedo F, Nakajima M, Llorens A, Barbosa E, Callejo S, Gajate C, Fabra A. 
Major co-localization of the extracellular-matrix degradative enzymes 
heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J 
1997; 327: 917-923. 
39. Hibbs MS, Bainton DF. Human neutrophil gelatinase is a component of specific 
granules. J Clin Invest 1989; 84: 1395-1402. 
40. Borregaard N, Lollike K, Kjeldsen L, Sengelov H, Bastholm L, Nielsen MH, 
Bainton DF. Human neutrophil granules and secretory vesicles. Eur J Haematol 
1993; 51: 187-198. 
41. Petrequin PR, Todd RF, 3rd, Devall LJ, Boxer LA, Curnutte JT, 3rd. 
Association between gelatinase release and increased plasma membrane 
expression of the Mo1 glycoprotein. Blood 1987; 69: 605-610. 
42. Diaz-Gonzalez F, Gonzalez-Alvaro I, Campanero MR, Mollinedo F, del Pozo 
MA, Munoz C, Pivel JP, Sanchez-Madrid F. Prevention of in vitro neutrophil-
endothelial attachment through shedding of L-selectin by nonsteroidal 
antiinflammatory drugs. J Clin Invest 1995; 95: 1756-1765. 
43. Gonzalez-Alvaro I, Carmona L, Diaz-Gonzalez F, Gonzalez-Amaro R, 
Mollinedo F, Sanchez-Madrid F, Laffon A, Garcia-Vicuna R. Aceclofenac, a 
new nonsteroidal antiinflammatory drug, decreases the expression and function 
of some adhesion molecules on human neutrophils. J Rheumatol 1996; 23: 723-
729. 
44. Manara FS, Chin J, Schneider DL. Role of degranulation in activation of the 
respiratory burst in human neutrophils. J Leukoc Biol 1991; 49: 489-498 
45. Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M, Borregaard N. 
Human neutrophil gelatinase: a marker for circulating blood neutrophils. 
Purification and quantitation by enzyme linked immunosorbent assay. Eur J 
Haematol 1992; 49: 180-191. 
46. Sengelov H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N. Subcellular 
localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils. J 
Clin Invest 1993; 92: 1467-1476. 
47. Mollinedo F. Isolation of human neutrophil plasma membranes employing 
neutrophil cytoplasts and changes in the cell-surface proteins upon cell 
activation. Biochim Biophys Acta 1986; 861: 33-43. 
48. Petrequin PR, Todd RF, 3rd, Smolen JE, Boxer LA. Expression of specific 
granule markers on the cell surface of neutrophil cytoplasts. Blood 1986; 67: 
1119-1125. 
49. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-
specific granule deficiency results from a novel mutation with loss of function of 
the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med 
1999; 189: 1847-1852. 
50. Gombart AF, Koeffler HP. Neutrophil specific granule deficiency and mutations 
in the gene encoding transcription factor C/EBP(epsilon). Curr Opin Hematol 
2002; 9: 36-42. 
51. Borregaard N, Kjeldsen L, Rygaard K, Bastholm L, Nielsen MH, Sengelov H, 
Bjerrum OW, Johnsen AH. Stimulus-dependent secretion of plasma proteins 
from human neutrophils. J Clin Invest 1992; 90: 86-96. 
  
27  
 
52. Calafat J, Kuijpers TW, Janssen H, Borregaard N, Verhoeven AJ, Roos D. 
Evidence for small intracellular vesicles in human blood phagocytes containing 
cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 1993; 81: 
3122-3129. 
53. Berger M, Wetzler E, August JT, Tartakoff AM. Internalization of type 1 
complement receptors and de novo multivesicular body formation during 
chemoattractant-induced endocytosis in human neutrophils. J Clin Invest 1994; 
94: 1113-1125. 
54. Kumar A, Wetzler E, Berger M. Isolation and characterization of complement 
receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies 
to the cytoplasmic tail of CR1. Blood 1997; 89: 4555-4565. 
55. Smith GP, Sharp G, Peters TJ. Isolation and characterization of alkaline 
phosphatase-containing granules (phosphasomes) from human 
polymorphonuclear leucocytes. J Cell Sci 1985; 76: 167-178. 
56. Borregaard N, Miller LJ, Springer TA. Chemoattractant-regulated mobilization 
of a novel intracellular compartment in human neutrophils. Science 1987; 237: 
1204-1206. 
57. Borregaard N, Christensen L, Bejerrum OW, Birgens HS, Clemmensen I. 
Identification of a highly mobilizable subset of human neutrophil intracellular 
vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 
1990; 85: 408-416. 
58. Sengelov H, Nielsen MH, Borregaard N. Separation of human neutrophil plasma 
membrane from intracellular vesicles containing alkaline phosphatase and 
NADPH oxidase activity by free flow electrophoresis. J Biol Chem 1992; 267: 
14912-14917. 
59. Sengelov H. Secretory vesicles of human neutrophils. Eur J Haematol Suppl 
1996; 58: 1-24 
60. Sengelov H, Borregaard N. Free-flow electrophoresis in subcellular 
fractionation of human neutrophils. J Immunol Methods 1999; 232: 145-152. 
61. Kjeldsen L, Sengelov H, Borregaard N. Subcellular fractionation of human 
neutrophils on Percoll density gradients. J Immunol Methods 1999; 232: 131-
143. 
62. Sengelov H, Voldstedlund M, Vinten J, Borregaard N. Human neutrophils are 
devoid of the integral membrane protein caveolin. J Leukoc Biol 1998; 63: 563-
566. 
63. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA 
levels during neutrophil maturation explains the heterogeneity of neutrophil 
granules. J Leukoc Biol 1999; 66: 989-995. 
64. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the 
target of multiple chromosomal translocations in human leukemia, is essential 
for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330 
65. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. 
Absence of granulocyte colony-stimulating factor signaling and neutrophil 
development in CCAAT enhancer binding protein alpha-deficient mice. Proc 
Natl Acad Sci U S A 1997; 94: 569-574 
66. Bjerregaard MD, Jurlander J, Klausen P, Borregaard N, Cowland JB. The in 
vivo profile of transcription factors during neutrophil differentiation in human 
bone marrow. Blood 2003; 101: 4322-4332. 
67. Verbeek W, Lekstrom-Himes J, Park DJ, Dang PM, Vuong PT, Kawano S, 
Babior BM, Xanthopoulos K, Koeffler HP. Myeloid transcription factor 
  
28 
  
C/EBPepsilon is involved in the positive regulation of lactoferrin gene 
expression in neutrophils. Blood 1999; 94: 3141-3150. 
68. Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB. Regulation of 
human neutrophil granule protein expression. Curr Opin Hematol 2001; 8: 23-
27. 
69. Gombart AF, Kwok SH, Anderson KL, Yamaguchi Y, Torbett BE, Koeffler HP. 
Regulation of neutrophil and eosinophil secondary granule gene expression by 
transcription factors C/EBP epsilon and PU.1. Blood 2003; 101: 3265-3273. 
70. Sengelov H, Kjeldsen L, Borregaard N. Control of exocytosis in early neutrophil 
activation. J Immunol 1993; 150: 1535-1543. 
71. Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. 
Mobilization of granules and secretory vesicles during in vivo exudation of 
human neutrophils. J Immunol 1995; 154: 4157-4165. 
72. Scepek S, Lindau M. Focal exocytosis by eosinophils--compound exocytosis 
and cumulative fusion. Embo J 1993; 12: 1811-1817. 
73. Lindau M, Hartmann J, Scepek S. Three distinct fusion processes during 
eosinophil degranulation. Ann N Y Acad Sci 1994; 710: 232-247 
74. Hartmann J, Scepek S, Hafez I, Lindau M. Differential regulation of exocytotic 
fusion and granule- granule fusion in eosinophils by Ca2+ and GTP analogs. J 
Biol Chem 2003:  
75. Petty HR, Francis JW, Todd RF, 3rd, Petrequin P, Boxer LA. Neutrophil C3bi 
receptors: formation of membrane clusters during cell triggering requires 
intracellular granules. J Cell Physiol 1987; 133: 235-242, 256. 
76. Lollike K, Lindau M, Calafat J, Borregaard N. Compound exocytosis of 
granules in human neutrophils. J Leukoc Biol 2002; 71: 973-980. 
77. Chandler DE, Bennett JP, Gomperts B. Freeze-fracture studies of chemotactic 
peptide-induced exocytosis in neutrophils: evidence for two patterns of secretory 
granule fusion. J Ultrastruct Res 1983; 82: 221-232 
78. Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem 1999; 
68: 863-911 
79. Ferro-Novick S, Jahn R. Vesicle fusion from yeast to man. Nature 1994; 370: 
191-193. 
80. Weber T, Zemelman BV, McNew JA, Westermann B, Gmachl M, Parlati F, 
Sollner TH, Rothman JE. SNAREpins: minimal machinery for membrane 
fusion. Cell 1998; 92: 759-772. 
81. Bark IC, Hahn KM, Ryabinin AE, Wilson MC. Differential expression of 
SNAP-25 protein isoforms during divergent vesicle fusion events of neural 
development. Proc Natl Acad Sci U S A 1995; 92: 1510-1514. 
82. Jagadish MN, Fernandez CS, Hewish DR, Macaulay SL, Gough KH, Grusovin 
J, Verkuylen A, Cosgrove L, Alafaci A, Frenkel MJ, Ward CW. Insulin-
responsive tissues contain the core complex protein SNAP-25 (synaptosomal-
associated protein 25) A and B isoforms in addition to syntaxin 4 and 
synaptobrevins 1 and 2. Biochem J 1996; 317: 945-954. 
83. Nabokina S, Egea G, Blasi J, Mollinedo F. Intracellular location of SNAP-25 in 
human neutrophils. Biochem Biophys Res Commun 1997; 239: 592-597. 
84. Ravichandran V, Chawla A, Roche PA. Identification of a novel syntaxin- and 
synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal 
tissues. J Biol Chem 1996; 271: 13300-13303. 
  
29  
 
85. Mollinedo F, Lazo PA. Identification of two isoforms of the vesicle-membrane 
fusion protein SNAP-23 in human neutrophils and HL-60 cells. Biochem 
Biophys Res Commun 1997; 231: 808-812. 
86. Shukla A, Corydon TJ, Nielsen S, Hoffmann HJ, Dahl R. Identification of three 
new splice variants of the SNARE protein SNAP- 23. Biochem Biophys Res 
Commun 2001; 285: 320-327. 
87. Sutton RB, Fasshauer D, Jahn R, Brunger AT. Crystal structure of a SNARE 
complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998; 395: 
347-353. 
88. Fasshauer D, Sutton RB, Brunger AT, Jahn R. Conserved structural features of 
the synaptic fusion complex: SNARE proteins reclassified as Q- and R-
SNAREs. Proc Natl Acad Sci U S A 1998; 95: 15781-15786. 
89. Weimbs T, Low SH, Chapin SJ, Mostov KE, Bucher P, Hofmann K. A 
conserved domain is present in different families of vesicular fusion proteins: a 
new superfamily. Proc Natl Acad Sci U S A 1997; 94: 3046-3051. 
90. Weimbs T, Mostov K, Low SH, Hofmann K. A model for structural similarity 
between different SNARE complexes based on sequence relationships. Trends 
Cell Biol 1998; 8: 260-262. 
91. Wong PP, Daneman N, Volchuk A, Lassam N, Wilson MC, Klip A, Trimble 
WS. Tissue distribution of SNAP-23 and its subcellular localization in 3T3- L1 
cells. Biochem Biophys Res Commun 1997; 230: 64-68. 
92. Chen F, Foran P, Shone CC, Foster KA, Melling J, Dolly JO. Botulinum 
neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes 
and cleaves cellubrevin unlike type A toxin which failed to proteolyze the 
SNAP-23 present. Biochemistry 1997; 36: 5719-5728. 
93. Brumell JH, Volchuk A, Sengelov H, Borregaard N, Cieutat AM, Bainton DF, 
Grinstein S, Klip A. Subcellular distribution of docking/fusion proteins in 
neutrophils, secretory cells with multiple exocytic compartments. J Immunol 
1995; 155: 5750-5759. 
94. Martin-Martin B, Nabokina SM, Lazo PA, Mollinedo F. Co-expression of 
several human syntaxin genes in neutrophils and differentiating HL-60 cells: 
variant isoforms and detection of syntaxin 1. J Leukoc Biol 1999; 65: 397-406. 
95. Smolen JE, Hessler RJ, Nauseef WM, Goedken M, Joe Y. Identification and 
cloning of the SNARE proteins VAMP-2 and syntaxin-4 from HL-60 cells and 
human neutrophils. Inflammation 2001; 25: 255-265. 
96. Mollinedo F, Santos-Beneit AM, Gajate C: The human leukemia cell line HL-60 
as a cell culture model to study neutrophil functions and inflammatory 
responses. Animal cell culture techniques. Edited by Clynes M. Heidelberg, 
Germany, Springer-Verlag, 1998, pp 264-297 
97. Lazo PA, Nadal M, Ferrer M, Area E, Hernandez-Torres J, Nabokina SM, 
Mollinedo F, Estivill X. Genomic organization, chromosomal localization, 
alternative splicing, and isoforms of the human synaptosome-associated protein-
23 gene implicated in vesicle-membrane fusion processes. Hum Genet 2001; 
108: 211-215. 
98. Staley JP, Guthrie C. Mechanical devices of the spliceosome: motors, clocks, 
springs, and things. Cell 1998; 92: 315-326. 
99. Mollinedo F, Vaquerizo MJ, Naranjo JR. Expression of c-jun, jun B and jun D 
proto-oncogenes in human peripheral-blood granulocytes. Biochem J 1991; 273: 
477-479. 
  
30 
  
100. Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, 
differentiation, and cellular oncogene expression. Blood 1987; 70: 1233-1244. 
101. Lubbert M, Herrmann F, Koeffler HP. Expression and regulation of myeloid-
specific genes in normal and leukemic myeloid cells. Blood 1991; 77: 909-924. 
102. Collado-Escobar D, Mollinedo F. Dexamethasone modifies the functional 
responses of the granulocytic differentiating HL-60 cells. Biochem J 1994; 299: 
553-559. 
103. Cabaniols JP, Ravichandran V, Roche PA. Phosphorylation of SNAP-23 by the 
novel kinase SNAK regulates t-SNARE complex assembly. Mol Biol Cell 1999; 
10: 4033-4041. 
104. Lang T, Bruns D, Wenzel D, Riedel D, Holroyd P, Thiele C, Jahn R. SNAREs 
are concentrated in cholesterol-dependent clusters that define docking and fusion 
sites for exocytosis. Embo J 2001; 20: 2202-2213. 
105. Vogel K, Roche PA. SNAP-23 and SNAP-25 are palmitoylated in vivo. 
Biochem Biophys Res Commun 1999; 258: 407-410. 
106. Chamberlain LH, Burgoyne RD, Gould GW. SNARE proteins are highly 
enriched in lipid rafts in PC12 cells: implications for the spatial control of 
exocytosis. Proc Natl Acad Sci U S A 2001; 98: 5619-5624. 
107. Chamberlain LH, Gould GW. The vesicle- and target-SNARE proteins that 
mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts 
present on distinct intracellular membranes. J Biol Chem 2002; 277: 49750-
49754. 
108. Verkade P, Simons K. Robert Feulgen Lecture 1997. Lipid microdomains and 
membrane trafficking in mammalian cells. Histochem Cell Biol 1997; 108: 211-
220. 
109. Keller P, Simons K. Cholesterol is required for surface transport of influenza 
virus hemagglutinin. J Cell Biol 1998; 140: 1357-1367. 
110. Lafont F, Verkade P, Galli T, Wimmer C, Louvard D, Simons K. Raft 
association of SNAP receptors acting in apical trafficking in Madin-Darby 
canine kidney cells. Proc Natl Acad Sci U S A 1999; 96: 3734-3738. 
111. Dupre S, Haguenauer-Tsapis R. Raft partitioning of the yeast uracil permease 
during trafficking along the endocytic pathway. Traffic 2003; 4: 83-96. 
112. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell 
Biol 2001; 2: 107-117. 
113. Chapman ER. Synaptotagmin: a Ca(2+) sensor that triggers exocytosis? Nat Rev 
Mol Cell Biol 2002; 3: 498-508. 
114. Pereira-Leal JB, Seabra MC. The mammalian Rab family of small GTPases: 
definition of family and subfamily sequence motifs suggests a mechanism for 
functional specificity in the Ras superfamily. J Mol Biol 2000; 301: 1077-1087. 
115. Mollinedo F, Nieto JM, Andreu JM. Cytoplasmic microtubules in human 
neutrophil degranulation: reversible inhibition by the colchicine analogue 2-
methoxy-5-(2',3',4'- trimethoxyphenyl)-2,4,6-cycloheptatrien-1- one. Mol 
Pharmacol 1989; 36: 547-555. 
116. Torres M, Coates TD. Function of the cytoskeleton in human neutrophils and 
methods for evaluation. J Immunol Methods 1999; 232: 89-109 
117. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell 
Biol 2000; 1: 31-39 
118. Vita F, Soranzo MR, Borelli V, Bertoncin P, Zabucchi G. Subcellular 
localization of the small GTPase Rab5a in resting and stimulated human 
neutrophils. Exp Cell Res 1996; 227: 367-373. 
  
31  
 
119. Perskvist N, Roberg K, Kulyte A, Stendahl O. Rab5a GTPase regulates fusion 
between pathogen-containing phagosomes and cytoplasmic organelles in human 
neutrophils. J Cell Sci 2002; 115: 1321-1330. 
120. Chaudhuri S, Kumar A, Berger M. Association of ARF and Rabs with 
complement receptor type-1 storage vesicles in human neutrophils. J Leukoc 
Biol 2001; 70: 669-676. 
121. Maridonneau-Parini I, Yang CZ, Bornens M, Goud B. Increase in the expression 
of a family of small guanosine triphosphate- binding proteins, rab proteins, 
during induced phagocyte differentiation. J Clin Invest 1991; 87: 901-907. 
122. Mahal LK, Sequeira SM, Gureasko JM, Sollner TH. Calcium-independent 
stimulation of membrane fusion and SNAREpin formation by synaptotagmin I. J 
Cell Biol 2002; 158: 273-282 
123. Nusse O, Serrander L, Lew DP, Krause KH. Ca2+-induced exocytosis in 
individual human neutrophils: high- and low- affinity granule populations and 
submaximal responses. Embo J 1998; 17: 1279-1288. 
124. Lindmark IM, Karlsson A, Serrander L, Francois P, Lew D, Rasmusson B, 
Stendahl O, Nusse O. Synaptotagmin II could confer Ca(2+) sensitivity to 
phagocytosis in human neutrophils. Biochim Biophys Acta 2002; 1590: 159-
166. 
125. Barrowman MM, Cockcroft S, Gomperts BD. Two roles for guanine nucleotides 
in the stimulus-secretion sequence of neutrophils. Nature 1986; 319: 504-507. 
126. Burgoyne RD. G proteins: control of exocytosis. Nature 1987; 328: 112-113. 
127. Philips MR, Abramson SB, Kolasinski SL, Haines KA, Weissmann G, 
Rosenfeld MG. Low molecular weight GTP-binding proteins in human 
neutrophil granule membranes. J Biol Chem 1991; 266: 1289-1298. 
128. Philips MR, Pillinger MH, Staud R, Volker C, Rosenfeld MG, Weissmann G, 
Stock JB. Carboxyl methylation of Ras-related proteins during signal 
transduction in neutrophils. Science 1993; 259: 977-980 
129. Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood 1995; 
86: 1649-1660 
130. Maridonneau-Parini I, de Gunzburg J. Association of rap1 and rap2 proteins 
with the specific granules of human neutrophils. Translocation to the plasma 
membrane during cell activation. J Biol Chem 1992; 267: 6396-6402. 
131. Mollinedo F, Perez-Sala D, Gajate C, Jimenez B, Rodriguez P, Lacal JC. 
Localization of rap1 and rap2 proteins in the gelatinase-containing granules of 
human neutrophils. FEBS Lett 1993; 326: 209-214. 
132. Francis JW, Balazovich KJ, Smolen JE, Margolis DI, Boxer LA. Human 
neutrophil annexin I promotes granule aggregation and modulates Ca(2+)-
dependent membrane fusion. J Clin Invest 1992; 90: 537-544 
133. Borregaard N, Kjeldsen L, Lollike K, Sengelov H. Ca(2+)-dependent 
translocation of cytosolic proteins to isolated granule subpopulations and plasma 
membrane from human neutrophils. FEBS Lett 1992; 304: 195-197. 
134. Le Cabec V, Maridonneau-Parini I. Annexin 3 is associated with cytoplasmic 
granules in neutrophils and monocytes and translocates to the plasma membrane 
in activated cells. Biochem J 1994; 303: 481-487. 
135. Sjolin C, Stendahl O, Dahlgren C. Calcium-induced translocation of annexins to 
subcellular organelles of human neutrophils. Biochem J 1994; 300 ( Pt 2): 325-
330 
  
32 
  
136. Movitz C, Sjolin C, Dahlgren C. Cleavage of annexin I in human neutrophils is 
mediated by a membrane-localized metalloprotease. Biochim Biophys Acta 
1999; 1416: 101-108 
137. Sjolin C, Movitz C, Lundqvist H, Dahlgren C. Translocation of annexin XI to 
neutrophil subcellular organelles. Biochim Biophys Acta 1997; 1326: 149-156 
138. Ernst JD. Annexin III translocates to the periphagosomal region when 
neutrophils ingest opsonized yeast. J Immunol 1991; 146: 3110-3114 
139. Blackwood RA, Smolen JE, Transue A, Hessler RJ, Harsh DM, Brower RC, 
French S. Phospholipase D activity facilitates Ca2+-induced aggregation and 
fusion of complex liposomes. Am J Physiol 1997; 272: C1279-1285 
140. Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, Roos D, 
Verhoeven AJ. Membrane surface antigen expression on neutrophils: a 
reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 
78: 1105-1111. 
141. Baggiolini M. The enzymes of the granules of polymorphonuclear leukocytes 
and their functions. Enzyme 1972; 13: 132-160 
142. Todd RF, 3rd, Arnaout MA, Rosin RE, Crowley CA, Peters WA, Babior BM. 
Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 
110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest 
1984; 74: 1280-1290. 
143. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin-
like protein of human neutrophil specific granules. FEBS Lett 1995; 368: 173-
176. 
144. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human 
antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and 
metamyelocytes and localized to specific granules in neutrophils. Blood 1997; 
90: 2796-2803. 
145. Saito N, Pulford KA, Breton-Gorius J, Masse JM, Mason DY, Cramer EM. 
Ultrastructural localization of the CD68 macrophage-associated antigen in 
human blood neutrophils and monocytes. Am J Pathol 1991; 139: 1053-1059. 
146. Olsson I. The intracellular transport of glycosaminoglycans 
(mucopolysaccharides) in human leukocytes. Exp Cell Res 1969; 54: 318-325. 
147. Buescher ES, Livesey SA, Linner JG, Skubitz KM, McIlheran SM. Functional, 
physical, and ultrastructural localization of CD15 antigens to the human 
polymorphonuclear leukocyte secondary granule. Anat Rec 1990; 228: 306-314. 
148. Murphy G, Bretz U, Baggiolini M, Reynolds JJ. The latent collagenase and 
gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J 1980; 
192: 517-525. 
149. Murphy G, Reynolds JJ, Bretz U, Baggiolini M. Collagenase is a component of 
the specific granules of human neutrophil leucocytes. Biochem J 1977; 162: 
195-197. 
150. Perretti M, Christian H, Wheller SK, Aiello I, Mugridge KG, Morris JF, Flower 
RJ, Goulding NJ. Annexin I is stored within gelatinase granules of human 
neutrophil and mobilized on the cell surface upon adhesion but not 
phagocytosis. Cell Biol Int 2000; 24: 163-174 
151. Grenier A, Chollet-Martin S, Crestani B, Delarche C, El Benna J, Boutten A, 
Andrieu V, Durand G, Gougerot-Pocidalo MA, Aubier M, Dehoux M. Presence 
of a mobilizable intracellular pool of hepatocyte growth factor in human 
polymorphonuclear neutrophils. Blood 2002; 99: 2997-3004. 
  
33  
 
152. Mirinics ZK, Calafat J, Udby L, Lovelock J, Kjeldsen L, Rothermund K, Sisodia 
SS, Borregaard N, Corey SJ. Identification of the presenilins in hematopoietic 
cells with localization of presenilin 1 to neutrophil and platelet granules. Blood 
Cells Mol Dis 2002; 28: 28-38. 
153. Mason DY, Cramer EM, Masse JM, Crystal R, Bassot JM, Breton-Gorius J. 
Alpha 1-antitrypsin is present within the primary granules of human 
polymorphonuclear leukocytes. Am J Pathol 1991; 139: 623-628. 
154. Pulido R, Lacal P, Mollinedo F, Sanchez-Madrid F. Biochemical and antigenic 
characterization of CD45 polypeptides expressed on plasma membrane and 
internal granules of human neutrophils. FEBS Lett 1989; 249: 337-342. 
155. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Structural and functional 
heterogeneity among peroxidase-negative granules in human neutrophils: 
identification of a distinct gelatinase- containing granule subset by combined 
immunocytochemistry and subcellular fractionation. Blood 1993; 82: 3183-
3191. 
156. Detmers PA, Zhou D, Powell D, Lichenstein H, Kelley M, Pironkova R. 
Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an 
intracellular compartment of neutrophils that contains alkaline phosphatase. J 
Immunol 1995; 155: 2085-2095. 
157. Pedersen TL, Plesner T, Horn T, Hoyer-Hansen G, Sorensen S, Hansen NE. 
Subcellular distribution of urokinase and urokinase receptor in human 
neutrophils determined by immunoelectron microscopy. Ultrastruct Pathol 2000; 
24: 175-182. 
158. Pereira HA, Erdem I, Pohl J, Spitznagel JK. Synthetic bactericidal peptide based 
on CAP37: a 37-kDa human neutrophil granule-associated cationic 
antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci U S A 
1993; 90: 4733-4737. 
159. Feuk-Lagerstedt E, Jordan ET, Leffler H, Dahlgren C, Karlsson A. Identification 
of CD66a and CD66b as the major galectin-3 receptor candidates in human 
neutrophils. J Immunol 1999; 163: 5592-5598. 
160. Matzner Y, Vlodavsky I, Bar-Ner M, Ishai-Michaeli R, Tauber AI. Subcellular 
localization of heparanase in human neutrophils. J Leukoc Biol 1992; 51: 519-
524. 
161. Jost CR, de Goede R, Fransen JA, Daha MR, Ginsel LA. On the origin of the 
FcRIII (CD16)-containing vesicle population in human neutrophil granulocytes. 
Eur J Cell Biol 1991; 54: 313-321. 
162. Nanda A, Brumell JH, Nordstrom T, Kjeldsen L, Sengelov H, Borregaard N, 
Rotstein OD, Grinstein S. Activation of proton pumping in human neutrophils 
occurs by exocytosis of vesicles bearing vacuolar-type H+-ATPases. J Biol 
Chem 1996; 271: 15963-15970. 
163. Weiss J, Olsson I. Cellular and subcellular localization of the 
bactericidal/permeability- increasing protein of neutrophils. Blood 1987; 69: 
652-659. 
164. Sengelov H, Kjeldsen L, Kroeze W, Berger M, Borregaard N. Secretory vesicles 
are the intracellular reservoir of complement receptor 1 in human neutrophils. J 
Immunol 1994; 153: 804-810. 
165. Jesaitis AJ, Buescher ES, Harrison D, Quinn MT, Parkos CA, Livesey S, Linner 
J. Ultrastructural localization of cytochrome b in the membranes of resting and 
phagocytosing human granulocytes. J Clin Invest 1990; 85: 821-835. 
  
34 
  
166. Ringel EW, Soter NA, Austen KF. Localization of histaminase to the specific 
granule of the human neutrophil. Immunology 1984; 52: 649-658. 
167. Lollike K, Kjeldsen L, Sengelov H, Borregaard N. Lysozyme in human 
neutrophils and plasma. A parameter of myelopoietic activity. Leukemia 1995; 
9: 159-164. 
168. Jack RM, Lowenstein BA, Nicholson-Weller A. Regulation of C1q receptor 
expression on human polymorphonuclear leukocytes. J Immunol 1994; 153: 
262-269. 
169. Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol 1990; 44: 1-8. 
170. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. 
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 
76: 1427-1435. 
171. Xu SY, Carlson M, Engstrom A, Garcia R, Peterson CG, Venge P. Purification 
and characterization of a human neutrophil lipocalin (HNL) from the secondary 
granules of human neutrophils. Scand J Clin Lab Invest 1994; 54: 365-376. 
172. Seveus L, Amin K, Peterson CG, Roomans GM, Venge P. Human neutrophil 
lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. 
Studies in bronchial and lung parenchymal tissue and peripheral blood cells. 
Histochem Cell Biol 1997; 107: 423-432. 
173. Bjerrum OW, Borregaard N. Dual granule localization of the dormant NADPH 
oxidase and cytochrome b559 in human neutrophils. Eur J Haematol 1989; 43: 
67-77. 
174. Cramer EM, Beesley JE, Pulford KA, Breton-Gorius J, Mason DY. 
Colocalization of elastase and myeloperoxidase in human blood and bone 
marrow neutrophils using a monoclonal antibody and immunogold. Am J Pathol 
1989; 134: 1275-1284. 
175. Sengelov H, Boulay F, Kjeldsen L, Borregaard N. Subcellular localization and 
translocation of the receptor for N- formylmethionyl-leucyl-phenylalanine in 
human neutrophils. Biochem J 1994; 299: 473-479. 
176. Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton-Gorius J. 
Ultrastructural localization of lactoferrin and myeloperoxidase in human 
neutrophils by immunogold. Blood 1985; 65: 423-432. 
177. Udby L, Calafat J, Sorensen OE, Borregaard N, Kjeldsen L. Identification of 
human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a 
subset of peroxidase-negative granules of neutrophils and in the granules of 
eosinophils. J Leukoc Biol 2002; 72: 462-469. 
178. Spitznagel JK, Dalldorf FG, Leffell MS, Folds JD, Welsh IR, Cooney MH, 
Martin LE. Character of azurophil and specific granules purified from human 
polymorphonuclear leukocytes. Lab Invest 1974; 30: 774-785. 
179. Bretz U, Baggiolini M. Biochemical and morphological characterization of 
azurophil and specific granules of human neutrophilic polymorphonuclear 
leukocytes. J Cell Biol 1974; 63: 251-269. 
180. Rotrosen D, Gallin JI, Spiegel AM, Malech HL. Subcellular localization of Gi 
alpha in human neutrophils. J Biol Chem 1988; 263: 10958-10964. 
181. Leffell MS, Spitznagel JK. Association of lactoferrin with lysozyme in granules 
of human polymorphonuclear leukocytes. Infect Immun 1972; 6: 761-765. 
182. Bjerrum OW, Bjerrum OJ, Borregaard N. Beta 2-microglobulin in neutrophils: 
an intragranular protein. J Immunol 1987; 138: 3913-3917. 
183. Kang T, Yi J, Guo A, Wang X, Overall CM, Jiang W, Elde R, Borregaard N, Pei 
D. Subcellular distribution and cytokine- and chemokine-regulated secretion of 
  
35  
 
leukolysin/MT6-MMP/MMP-25 in neutrophils. J Biol Chem 2001; 276: 21960-
21968. 
184. Elbim C, Reglier H, Fay M, Delarche C, Andrieu V, El Benna J, Gougerot-
Pocidalo MA. Intracellular pool of IL-10 receptors in specific granules of human 
neutrophils: differential mobilization by proinflammatory mediators. J Immunol 
2001; 166: 5201-5207. 
185. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil 
gelatinase-associated lipocalin as a novel matrix protein of specific granules in 
human neutrophils. Blood 1994; 83: 799-807. 
186. Morgan CP, Sengelov H, Whatmore J, Borregaard N, Cockcroft S. ADP-
ribosylation-factor-regulated phospholipase D activity localizes to secretory 
vesicles and mobilizes to the plasma membrane following N- formylmethionyl-
leucyl-phenylalanine stimulation of human neutrophils. Biochem J 1997; 325: 
581-585. 
187. Kjeldsen L, Cowland JB, Johnsen AH, Borregaard N. SGP28, a novel matrix 
glycoprotein in specific granules of human neutrophils with similarity to a 
human testis-specific gene product and a rodent sperm-coating glycoprotein. 
FEBS Lett 1996; 380: 246-250. 
188. Canonne-Hergaux F, Calafat J, Richer E, Cellier M, Grinstein S, Borregaard N, 
Gros P. Expression and subcellular localization of NRAMP1 in human 
neutrophil granules. Blood 2002; 100: 268-275. 
189. Witko-Sarsat V, Cramer EM, Hieblot C, Guichard J, Nusbaum P, Lopez S, 
Lesavre P, Halbwachs-Mecarelli L. Presence of proteinase 3 in secretory 
vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from 
azurophil granules. Blood 1999; 94: 2487-2496. 
190. Cross AS, Wright DG. Mobilization of sialidase from intracellular stores to the 
surface of human neutrophils and its role in stimulated adhesion responses of 
these cells. J Clin Invest 1991; 88: 2067-2076. 
191. Goldschmeding R, van Dalen CM, Faber N, Calafat J, Huizinga TW, van der 
Schoot CE, Clement LT, von dem Borne AE. Further characterization of the NB 
1 antigen as a variably expressed 56- 62 kD GPI-linked glycoprotein of plasma 
membranes and specific granules of neutrophils. Br J Haematol 1992; 81: 336-
345. 
192. Plesner T, Ploug M, Ellis V, Ronne E, Hoyer-Hansen G, Wittrup M, Pedersen 
TL, Tscherning T, Dano K, Hansen NE. The receptor for urokinase-type 
plasminogen activator and urokinase is translocated from two distinct 
intracellular compartments to the plasma membrane on stimulation of human 
neutrophils. Blood 1994; 83: 808-815. 
193. Csernok E, Ludemann J, Gross WL, Bainton DF. Ultrastructural localization of 
proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in 
Wegener's granulomatosis. Am J Pathol 1990; 137: 1113-1120. 
194. Gutkind JS, Robbins KC. Translocation of the FGR protein-tyrosine kinase as a 
consequence of neutrophil activation. Proc Natl Acad Sci U S A 1989; 86: 8783-
8787. 
195. Kane SP, Peters TJ. Analytical subcellular fractionation of human granulocytes 
with reference to the localization of vitamin B12-binding proteins. Clin Sci Mol 
Med 1975; 49: 171-182. 
196. Porteu F, Nathan CF. Mobilizable intracellular pool of p55 (type I) tumor 
necrosis factor receptors in human neutrophils. J Leukoc Biol 1992; 52: 122-
124. 
  
36 
  
197. Volck B, Price PA, Johansen JS, Sorensen O, Benfield TL, Nielsen HJ, Calafat 
J, Borregaard N. YKL-40, a mammalian member of the chitinase family, is a 
matrix protein of specific granules in human neutrophils. Proc Assoc Am 
Physicians 1998; 110: 351-360. 
198. Laszlo L, Doherty FJ, Watson A, Self T, Landon M, Lowe J, Mayer RJ. 
Immunogold localisation of ubiquitin-protein conjugates in primary 
(azurophilic) granules of polymorphonuclear neutrophils. FEBS Lett 1991; 279: 
175-178. 
199. Quinn MT, Mullen ML, Jesaitis AJ, Linner JG. Subcellular distribution of the 
Rap1A protein in human neutrophils: colocalization and cotranslocation with 
cytochrome b559. Blood 1992; 79: 1563-1573. 
200. Suchard SJ, Burton MJ, Stoehr SJ. Thrombospondin receptor expression in 
human neutrophils coincides with the release of a subpopulation of specific 
granules. Biochem J 1992; 284: 513-520. 
 
  
37  
 
 
LEGENDS TO FIGURES 
 
Figure 1. Schematic representation of the different stages of neutrophil maturation in 
bone marrow. The approximate cell size and the relative percentage of each maturation 
stage with respect to the total nucleated cell population in bone marrow are shown in 
parentheses. Peroxidase-positive granules (solid black) and peroxidase-negative 
granules (open forms) are indicated. Neutrophils, produced from stem cells in bone 
marrow, spend about two weeks in this maturation compartment. Mature PMNs are 
released to the peripheral blood where they spend about 10 h before entering the tissue. 
In tissues, neutrophils are supposed to function for 1-2 days before dying by apoptosis.  
 
Figure 2. Putative involvement of tertiary granule mobilization in modulating major 
neutrophil functions. The characteristic content of tertiary granules makes them a 
central player in neutrophil function. Fusion of tertiary granules with the plasma 
membrane (exocytosis) leads to: a) increased exposure of CD11b/CD18 at the cell 
surface that could enhance neutrophil attachment to endothelium, b) release of 
gelatinase and heparanse that mediate the neutrophil passage through capillary walls 
into the tissue, and c) incorporation of cytochrome b558 into the plasma membrane with 
the subsequent generation of superoxide anion and oxygen metabolites that perturb the 
organization of vascular endothelial cell membranes and increase vascular permeability. 
Thus, exocytosis of tertiary granules could have a role in the regulation of early 
neutrophil responses after cell stimulation, such as neutrophil adhesion and diapedesis.  
Fusion of tertiary granules with phagocytic vacuoles (phagocytosis) lead to the 
generation of hydrogen peroxide, whose germicidal activity is largely increased by 
myeloperoxidase and a halide after fusion of azurophilic granules with the phagosome, 
and to the acidification of the phagosome allowing the action of acid hydrolases. 
  
Figure 3. Possible mechanisms in exocytosis of cytoplasmic granules. Simple 
exocytosis, where each granule fuses independently with the plasma membrane. 
Compound exocytosis, where two or more granules fuse with each other in the cytosol 
prior to their fusion with the plasma membrane. Cumulative fusion, where one granule 
fuses initially with the plasma membrane, and subsequently additional granules fuses 
with the granule already engaged in fusion. 
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Figure 4. Model for the involvement of SNARE proteins in the exocytosis of tertiary 
and specific granules in human neutrophils. This schematic diagram is designed to 
portray a currently plausible mechanism for the involvement of SNAREs in human 
neutrophil exocytosis. Syntaxin 4, syntaxin 6 and VAMP-2 contain transmembrane 
domains, whereas SNAP-23 is bound to the granule membrane through a palmitoylated 
cysteine-rich membrane anchor domain located at the central part of the molecule 
connecting the helical SNARE motifs. Although not represented in the scheme for 
simplicity, all four SNARE motifs of the heterodimer are arranged in parallel, with the 
N termini at one end of the complex and the C termini at the membrane-anchor end. 
Table I 
Constituents of human neutrophil granules and secretory vesicles 
 
 
Azurophil granules 
 
 
Specific granules 
 
Tertiary granules 
 
Secretory vesicles 
Membrane Matrix Membrane Matrix Membrane Matrix Membrane Matrix 
CD63 140 Acid β-
glycerophosphata
se 141 
CD11c/CD18 142 Cathelicidin 
(hCAP-18) 143,144 
CD11b/CD18 28,29 Acetyltransferase 
30 
Alkaline 
phosphatase 54 
Albumin 51,54 
CD68 145 Acid 
mucopolysacchar
ide 146 
CD15 147 Collagenase 148,149 CD11c/CD18 29,41 Annexin I 150 CD11b/CD18 
46,52,54 
Hepatocyte 
growth factor 
(HGF) 151 
Presenilin-1 152 α1-Antitrypsin 153 CD45 28,154 Gelatinase  39,155 CD45 28,154 Gelatinase 
13,15,37,38,155 
CD14 156 Tetranectin 57 
Urokinase-type 
plasminogen 
activator-R 157 
Azurocidin/CAP3
7/heparin binding 
protein 158 
CD66a 147,159 Heparanase 160 CD66a 159 Heparanase 38 CD16 (FcRIII) 
54,156,161 
 
V-type H+-
ATPase 162 
Bactericidal/perm
eability 
increasing protein 
(BPI) 163 
CD66b (formerly 
named CD67) 
4,147,159 
Hepatocyte 
growth factor 
(HGF) 151 
CD66b (formerly 
named CD67) 
4,159 
Hepatocyte 
growth factor 
(HGF) 151 
 
CR1 (CD35) 54,164  
 Cathepsins 141 Cytochrome b558 
165 
Histaminase 166 Cytochrome b558 
14 
Lysozyme 167 C1q-receptor 168  
 Defensins (HNP-
1,2,3) 169,170 
Fibronectin-R 26 Human 
neutrophil 
lipocalin (HNL) 
171,172 
1-diacylglycerol 
lipase 34 
β2-Microglobulin Cytochrome b558 
52,173 
 
 Elastase 174 fMLP-R 175 Lactoferrin 176 fMLP-R 175 SGP28 (CRISP-
3) 177 
DAF 54  
 β-Glucuronidase 
178,179 
G-protein α 
subunit 180 
Lysozyme 179,181 19-kD (P1C3) 
protein 36 
Urokinase-type 
plasminogen 157 
fMLP-R 175  
 β-
Glycerophosphat
ase 179 
19-kD (P1C3) 
protein 36 
β2-Microglobulin 
182 
Leukolysin 183  Leukolysin 183  
 Lysozyme 179,181 IL10-R 184 NGAL 185 2-
monoacylglycerol 
lipase 34 
 Phospholipase D 
186 
 
 α-Mannosidase 
141 
Laminin-R 26 SGP28 (CRISP-
3) 177,187 
Nramp1 188  Proteinase-3 189  
 Myeloperoxidase 
176 
Leukolysin 183 Sialidase 190 plasminogen 
activator-R 157 
 Rab 3a 120  
 N-Acetyl-β-
glucosaminidase 
179 
NB 1 antigen 191 Urokinase-type 
plasminogen 192 
Rap1 131  Rab 4 120  
 Proteinase-3 193 p55c-fgr 194 Vitamin B12- Rap2 (Rap2B) 131  Rab 5a 120  
  
40 
  
binding protein 
195 
 Sialidase 190 p55 TNF-R 196 YKL-40, also 
called human 
cartilage 
glycoprotein-39 
(HC gp-39) 197 
 
SNAP-23 3  SCAMP 93  
 Ubiquitin-protein 
conjugates 198 
Rap 1 (Rap1A) 
130,199 
 SCAMP 93  Urokinase-type 
plasminogen 
activator-R 192  
 
 Urokinase-type 
plasminogen 
activator 157 
Rap 2 130  Ubiquinone 14  VAMP-2 93  
  SNAP-23 3  Urokinase-type   V-type H+-
ATPase 162 
 
  SCAMP 93  VAMP-2 4,93    
  Thrombospondin-
R 200 
 V-type H+-
ATPase 15,162 
   
  Urokinase-type 
plasminogen 
activator-R 192 
     
  VAMP-2 4      
  Vitronectin-R 26      
 
 
 
 
 
 
  
Table II 
Expression of SNARE proteins in human neutrophils and HL-60 cells 
 
Gene PMN 
expression 
PMN subcellular 
location 
HL-60 HL-60(DMSO)* 
SNAP-23 R, P 3,85 Specific and gelatinase-
rich tertiary granules 
(major), plasma membrane 
(minor) 3 
R 85 R 85 
SNAP-25 P 83 Cytoplasmic granules 83 ND ND 
Syntaxin 1 R, P 94 Cytoplasmic granules 
(major), plasma membrane 
(minor) 94 
R 94 R 94 
Syntaxin 3 R 94 ND R 94 R; upregulation during 
differentiation 94 
Syntaxin 4 R, P 4,93,94 Plasma membrane 4,93 R 94 R; upregulation during 
differentiation 94,95 
Syntaxin 5 R 94 ND R 94 R 94 
Syntaxin 6 R, P 3,94 Plasma membrane 3 R 94 R; upregulation during 
differentiation 94 
Syntaxin 7 R 94 ND -- R; upregulation during 
differentiation 94 
Syntaxin 9 R 94 ND R 94 R 94 
Syntaxin 11 R 94 ND R 94 R; upregulation during 
differentiation 94 
Syntaxin 16 R 94 ND R 94 R 94 
VAMP-2 R, P 4 Specific, gelatinase-rich 
tertiary granules, and 
secretory vesicles 4,93 
R 95 R; upregulation during 
differentiation 95 
 
* HL-60(DMSO) are HL-60 cells differentiated towards neutrophils by a 4-day incubation with 
1.3% DMSO. 
 
R, mRNA evidence (RT-PCR, Northern blot), cloning and sequencing. 
P, protein evidence (Western blot) 
ND, not determined 
